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Host diversity is one of the key factors that determine why pathogens can emerge 
and cause epidemics, the scale of an epidemic, and host-pathogen coevolution. 
Although the effects of host diversity on pathogen spread are well-described, we 
currently lack a detailed understanding of the ecological and evolutionary 
mechanisms that underpin them. The interactions between phage and bacteria with 
a CRISPR-Cas immune system are a tractable model system to study how host 
density and genetic diversity impacts phage epidemiology, evolution and coevolution 
between the host and the phage. In this thesis, I first summarize existing literature on 
the role of host genetic diversity on host-parasite interactions. I then present 
experiments that explore how population bottlenecks, which impact both host density 
and genetic diversity, affect the epidemiology and evolution of phage. I find that 
bottlenecks result in more rapid phage extinction, which is driven primarily by the 
changes in host density. Next, I explore how manipulations of host genetic diversity 
alter the epidemiology and evolution of a phage that can infect a single host 
genotype in the population. I find that greater diversity results in protection of the 
susceptible host due to reduced contact rates with phage. I also find evidence for 
interaction between host diversity, phage population size, and the likelihood of phage 
evolution. Finally, I examine the coevolutionary interaction between phage and 
bacteria with CRISPR immune systems. I find that bacterial populations initially 
evolve diversity in their CRISPR-Cas immune systems that is sufficiently low for an 
escalating arms-race dynamic to ensue, that lasts until diversity in the CRISPR-Cas 
resistance alleles becomes too high, causing phage extinction.   
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There are many examples of how the emergence and spread of infectious diseases 
have impacted and shaped histories, both large and small (Diamond, 2002). 
Mythological plagues, such as the pestilence and boils visited upon the people of 
Egypt by the god of the Old Testament, have long formed part of human ideas about 
divinity and the supernatural. The Plague of Athens in 430BCE, generally attributed 
to a typhoid fever (Papagrigorakis et al., 2008; Littman, 2009), not only killed a 
significant proportion of Athenians, but changed the course of a war (Thucydides et 
al., 1972) and inspired numerous works of Western art and literature. The Plague of 
Justinian (541-549 CE), caused by a strain of Yersinia pestis that swept through 
Europe and the Middle East (Harbeck et al., 2013), permanently altered the balance 
of power in the Christian church and changed the course of European history 
(Rosen, 2010). The most well-known pandemic of Y. pestis, the Black Death, 
decimated the populations of Eurasia and Africa between 1347 and 1351, killing 
around a third of Europeans (Gould, 1966). The consequences of the Black Death 
were vast: it was a key trigger for the Hundred Years War between England and 
France (Turchin, 2018); it deepened antisemitism across Europe (Moore, 2008; 
Nirenberg, 2015); labour and land reforms in response to the vast loss of life 
realigned the feudal system, which in England led to the Peasant’s Revolt (Dyer, 
2002); and architecture and art moved toward greater realism and emotive 
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expression (Honour & Fleming, 2005). The use of a single-cultivar clone of potato 
that was susceptible to a strain of late blight fungus (Phytomophthora infestans) 
triggered the Irish potato famine (Machida-Hirano, 2015). 
 
In the last century, three examples of infectious diseases stand out. The huge 
mortality of the 1918 flu pandemic, caused by a strain of H1N1 influenza A virus, was 
mainly due to the economic and political upheavals immediately following the First 
World War (1914-18), rather than the virus being unusually deadly (Brundage & 
Shanks, 2007; Morens & Fauci, 2007). The 1918 pandemic also greatly influenced 
the preparedness of public health systems toward another similarly infectious global 
flu outbreak. The ongoing HIV/AIDS pandemic, which as of 2018 killed around 32 
million people (World Health Organisation, 2020), originated as SIV in non-human 
primates and adapted to infect humans in what is now the Democratic Republic of 
Congo sometime in the early 20th Century (Sharp & Hahn, 2011). The 
disproportionate impact of HIV/AIDS on the gay community and people in sub-
Saharan African countries demonstrates how politics, colonialism, and prejudice can 
align to heighten the burden of infectious diseases on marginalised communities. 
Finally, the impacts of SARS-CoV-2, which likely emerged in a bat reservoir before 
crossing over to humans (Wu et al., 2020), are still developing. This most recent 
pandemic has highlighted deep social inequalities, for example with severe cases 
and mortality disproportionately falling on black and brown communities in the UK as 






There is a breadth of evidence that crop diversity can prevent and/or mitigate the 
impact of pathogens, and that this can maintain or increase yields (Smithson & 
Lenne, 1996; Mundt, 2002; Borg et al., 2018; Reiss & Drinkwater, 2018). Many 
subsistence peasant agriculturalists and indigenous peoples have long recognised 
and advocated the benefits of crop diversity (Mann, 2005; Chohan, 2017; Laughton, 
2017). The benefits of cultivar mixtures were first experimentally studied in small 
grain crops prior to World War Two (Frankel, 1939), and later, work by Elton (1958) 
formalised the idea of a “monoculture effect” on disease susceptibility and 
transmission in crop species. The first systematic review of crop diversity showed 
some disease reduction benefits (Smithson & Lenne, 1996), and a later review by 
Mundt (2002) showed that cultivar mixes can effectively limit disease in small grain 
species. More recently, meta-analyses by Kiær et al. (2009) and Reiss and 
Drinkwater (2018) found that increased cultivar diversity based on disease traits led 
to significant yield increases. Reiss and Drinkwater (2018) note that the benefit of 
functional diversity in terms of disease was most important when other physical 
stressors are present. In other words, more diverse crop assemblages generate 
higher yields in the context of other abiotic perturbations compared to less diverse 
assemblages. This highlights the synergy between biotic and abiotic pressures, and 
is also particularly relevant given the expectation that both disease and physical 
pressure on crops is expected to increase with climate breakdown (Tripathi et al., 
2016). As changing climatic conditions continue to threaten the food supply, 
increasing crop diversity will become even more important.  
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Like crops, loss of genetic diversity in animal populations may render declining 
populations more vulnerable to disease. Numerous studies of wild host-pathogen 
systems have shown that host genetic diversity reduces pathogen prevalence and/or 
disease burden (O'Brien et al., 1985; Thorne & Williams, 1988; Meagher, 1999; 
Acevedo-Whitehouse et al., 2003; Pearman & Garner, 2005; Whiteman et al., 2007; 
Ashby & King, 2015; van Houte et al., 2016b; Eastwood et al., 2017; López-Uribe et 
al., 2017; Morley et al., 2017). A recent meta-analysis provided broad support for a 
negative effect of host population genetic diversity on parasite success across the 
tree of life (Ekroth et al., 2019). In this study, the authors noted that work in the field 
versus laboratory influenced the size of the effect, and that the success of 
microparasites (i.e. viruses, prokaryotes, and fungi) tended to be more affected by 
host diversity. This latter effect may be explained by physiological differences in how 
macro- and microparasites tend to interact with their hosts. Where macroparasites 
more often encounter physical and/or innate immune defences, such as skin 
thickness or an inflammatory response, microparasites often have more complex 
cellular or molecular interactions with the host immune system. As such, 
microparasites must evade or overcome host mechanisms with very high 
dimensionality and evolutionary potential, and so they may be more sensitive to 
diversity in such mechanisms. 
 
The caveats to the diversity-disease effect highlighted by Ekroth et al. (2019) 
suggest that, while it is a useful heuristic that generally holds, specific host-pathogen 
systems in different contexts may show different responses. For example, in 
populations of the buff-tailed bumblebee (Bombus terrestris), the microsporidian 
parasite Nosema bombi is more successful in genetically homogeneous populations 
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compared to heterogeneous populations of B. terrestris (Baer & Schmid-Hempel, 
1999; Baer & Schmid‐Hempel, 2001, 2003), but the trypanosomelid Crithidia bombi 
is equally successful in both diverse and non-diverse hosts populations (Baer & 
Schmid-Hempel, 1999). In experimental populations of the ant Formica selysi 
infected with a single pathogen species, host genetic diversity does not always 
reduce pathogen success (Reber et al., 2008; Schmidt et al., 2011). Finally, because 
parasite success can be measured in different ways, the sign of the effect of host 
diversity - or indeed if an effect is detected at all – can vary between and within 
studies. Desai and Currie (2015) illustrate this in the honeybee Apis mellifera 
populations. Genetic diversity negatively affected pathogen success when infection 
prevalence or parasite load was calculated, but not when host survival was 
considered. 
 
While the literature reviewed above clearly shows that diversity broadly benefits 
hosts, there is comparatively less clarity regarding why diversity is beneficial. In 
considering the ecological and evolutionary mechanisms that can drive the diversity-
disease effect, the key questions to pose would be why emergence of infectious 




Early deterministic epidemiological models of pathogen spread assume that whether 
or not a pathogen spreads in a host population is due to the value of R0, which is the 
expected number of secondary infections per primary case in a fully susceptible 
population (Anderson & May, 1992; Diekmann & Heesterbeek, 2000). In this 
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simplified scenario, an epidemic occurs if R0 > 1, and if R0 < 1, it decelerates or ends. 
Although the underlying assumptions of these kinds of deterministic models are 
limited, they have nonetheless been extremely useful in developing public health 
interventions and policies, such as vaccination programmes.  
 
Simple probabilistic models which take into account host demographic stochasticity 
such as transmission, mortality and recovery rates, as well as the number of initially 
infected individuals show that pathogen extinction still occurs when R0 < 1, even with 
multiple introduction events into the host population (Gandon et al., 2013). When R0 
> 1 in such models, there is a positive non-linear relationship between R0 and the 
number of introduced infected individuals. Conceivably, a pathogen with a sufficiently 
high R0 can emerge in an uninfected host population from a single infected individual 
(May et al., 2001). 
 
Pathogens evolve, but epidemiological models like those discussed above tend to 
ignore pathogen evolution. Antia et al. (2003) illustrate how pathogens with an initial 
R0 of less than one can still establish an epidemic after evolutionary rescue. If a 
pathogen is maintained in a novel host population by sufficient stochastic 
transmission chains and its mutation rate is not 0, novel mutations can arise that 
increase R0 to or above 1. When multiple evolutionary changes are required for 
rescue, the probability of emergence decreases and becomes much more sensitive 
to the initial value of R0. Evolutionary change must occur sufficiently fast to rescue a 
novel pathogen from extinction and lead to emergence. 
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Novel pathogens may circulate back into a reservoir population, potentially 
increasing the length of stochastic transmission chains and contributing to 
evolutionary rescue and emergence. Assuming that a mutation that increases 
transmission in the novel host is neutral in the reservoir, the time needed for further 
adaptive mutations to arise in the pathogen may be extended (Reluga et al., 2007). 
The process of back-circulation to a reservoir population is conceptually similar to a 
scenario in which novel hosts vary in epidemiologically-relevant ways, such that 
some hosts are “higher quality” from the perspective of the pathogen.  
 
Most theoretical models treat host populations as homogeneous. However, this 
assumption is broken in nature. Recent progress has been made to overcome this 
disconnect and shed light on how host diversity can limit both the spread and 
evolution of pathogens.  
 
It is clear that host genetic diversity can successfully limit pathogen spread. This can 
be explained by the dilution effect (Keesing et al., 2006; Keesing et al., 2010; Ostfeld 
& Keesing, 2012). The dilution effect, in terms of within-species immune diversity, is 
suggested to arise because increasing the number of resistant or low-quality 
individuals in a host population decreases the proportion of susceptible individuals in 
that population. This can reduce contact rates between free-living pathogens and 
susceptible hosts (Mitchell et al., 2002; Dobson, 2004; Gandon, 2004; Dennehy et 
al., 2007; Roscher et al., 2007; Lively, 2010) or increase the likelihood of stochastic 
fixation of resistance alleles (Quigley et al., 2012; Gokhale et al., 2013), which in turn 
can reduce R0. There is much observational support for the role of a dilution effect in 
multi-species host–pathogen systems [reviewed in Civitello et al. (2015)]. Further, 
 19 
the dilution effect is analogous with the concept of herd immunity in epidemiology 
(Topley & Wilson, 1923). Herd immunity is based on the idea that the presence 
and/or proximity of immune or partially-immune individuals reduces the risk of 
infection for susceptible individuals by suppressing R0 (Fox et al., 1971; Anderson & 
May, 1985; John & Samuel, 2000; Stephens, 2008). The public health application of 
herd immunity (or the dilution effect) relates to the critical vaccination level VC, which 
is the proportion of the population that must be vaccinated in order to achieve herd 
immunity and an R0 < 1 (Anderson & May, 1992; Fine, 1993; Heesterbeek, 2002). 
Evidence for the ability of herd immunity to successfully limit and in some cases, 
eradicate, a pathogen, is widespread in the epidemiological literature (Hamer, 1906; 
Hedrich, 1933; Böttiger, 1987; Reichert et al., 2001; Heymann & Aylward, 2008; Fine 
et al., 2011).  
 
The dilution effect in these contexts is a relative dilution effect – host diversity 
reduces contact probability between infected and susceptible hosts, which in turn 
reduces pathogen transmission. Crucially, this is functionally different from an 
absolute dilution effect, where contact probability and transmission is limited instead 
by spatiotemporal factors. This is a non-trivial distinction, as absolute and relative 
dilution effects are likely to differ in their ecological and evolutionary consequences. 
Selection for pathogen escape may be elevated by relative dilution due to more 
frequent contact with less-suitable hosts; host-pathogen coexistence and coevolution 
under absolute dilution may be limited by the spatiotemporal availability of host 
resources instead of host diversity; or stochastic transmission chains required for 
evolutionary emergence may be more likely to be maintained when less-suitable 
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hosts are available under relative dilution. The process and patterns of absolute 
versus relative dilution effects are explored in Chapters 2 and 3, respectively. 
 
While the dilution effect is most often applied to describe why existing pathogens are 
limited by host diversity, the process is analogous to the idea that diversity reduces 
stochastic transmission chains discussed in detail above. Extending the evolutionary 
epidemiology framework of stochastic transmission chains while R0 < 1 to account 
for host heterogeneity, for example in terms of susceptibility, infectiousness, or 
contact patterns, has suggested several mechanisms by which host diversity may 
influence pathogen evolution. When a heterogeneous population consists of hosts 
that vary in their individual R0 i.e. super-spreaders (Woolhouse et al., 1997), the 
probability of emergence is reduced but the epidemic is larger if evolutionary rescue 
does occur (Lloyd-Smith et al., 2005). This is because heterogeneity can reduce the 
length and/or frequency of stochastic transmission chains owing to the presence of 
low-quality hosts, an effect which is not offset by the presence of high-quality hosts. 
However, in the event that adaptation leads to an R0 > 1, the presence of high-quality 
hosts increases the size of the resultant epidemic (Lloyd-Smith et al., 2005). 
 
In general, theory predicts that the probability of evolutionary emergence decreases 
when host diversity increases, but this relationship is thought to be non-linear. 
Benmayor et al. (2009) showed that evolutionary emergence of novel phage 2 
genotypes peaked at intermediate frequencies of susceptible P. fluorescens hosts 
due to an optimal balance between selection pressure, contact rates, and mutation 
supply. Chabas et al. (2018) extend this using a mechanistic model of pathogen 
emergence in a diverse host population where hosts differ in how they resist 
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infection. Their model predicts that evolutionary emergence is maximised at 
intermediate susceptible host frequencies, and experimentally validate these 
predictions using hosts populations that vary in CRISPR-Cas (Clustered Regularly 
Interspaced Short Palindromic Repeats; CRISPR-associated) allele diversity 
challenged with lytic phage. Building on theory discussed throughout this section and 
in agreement with Benmayor et al. (2009), Chabas et al. (2018) suggest that this 
effect of intermediate host heterogeneity is due to two opposing selective forces. 
While R0 < 1, a higher frequency of susceptible hosts increases the length of 
stochastic transmission chains that limit pathogen extinction. Simultaneously, 
increasing host diversity increases the selection pressure for novel variants. If the 
frequency of susceptible hosts is high due to low host diversity, then pathogen 
reproduction is high and there is limited selection for evolutionary novelty. In the 
most extreme scenario, a monoclonal host population, the pathogen can infect all 
individuals and there is no selection. By contrast, when the frequency of susceptible 
hosts is low due to high host diversity, transmission chains go extinct too quickly for 
novel variants to survive and increase R0 above 1. These two effects, acting in 
dynamic tension, can consequently maximise evolutionary emergence at 
intermediate host diversity. 
 
By contrast, a phenomenological approach that makes explicit the contact process 
between hosts and the network of mutations available to the pathogen suggest that 
host heterogeneity may actually increase the likelihood of evolutionary emergence 
(Alexander & Day, 2010), and the evolutionary emergence of phage 6 has been 
shown to increase when advantageous mutations are “nearby” in the mutational 
network (Burch & Chao, 2000). This approach only accounts for differences in 
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contact rates, rather than host susceptibility. Despite these differing predictions, the 
probability of emergence in a heterogeneous host following evolutionary rescue is 
particularly sensitive to stochastic effects when R0 ~ 1 (Yates et al., 2006; Alexander 
& Day, 2010).  
 
Experimental tests: bacteria-phage 
 
One of the major challenges to testing theoretical predictions of the effect of host 
diversity on pathogen spread is that, in almost every host-pathogen system, the 
genetics of resistance and infectivity are either unknown or not amenable to 
experimentation. Experiments with bacteria and phage have been used to test some 
of the theoretical predictions on the role of host diversity in pathogen evolutionary 
emergence and ecology. Several excellent reviews discuss why and how studies of 
bacteria-phage have contributed to our understanding of host-pathogen interactions, 
for example in terms of linking phenotypic with genotypic change, coevolutionary 
dynamics, and microbial community processes (Bohannan & Lenski, 2000; Buckling 
& Brockhurst, 2012; Dennehy, 2012; Koskella, 2014; Koskella & Brockhurst, 2014). 
Of particular relevance to this thesis is the contribution of bacteria-phage studies to 
our understanding of the evolution of host range, and its relationship to host-
pathogen coevolution.  
 
Early work in several different bacteria-phage systems, but predominantly using 
Escherichia coli B, suggested that bacteria-phage coevolution was fundamentally 
limited [reviewed in Dennehy (2012)]. To explain this, Lenski and Levin (1985) 
suggested that coevolution ceased once de novo modifications to cell surface 
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receptors arose that prevented phage attachment. Further, they argued that 
bacteria-phage are locked into “mutational asymmetry”. This arises because phage 
must bind to a specific surface receptor to be infective. If that receptor changes or is 
lost, phage must modify the interaction or switch to an entirely new receptor. Lenski 
and Levin (1985) argued that this is much more mutationally and evolutionarily 
constrained compared to bacteria, which have multiple routes to receptor 
modification or loss. In other words, the “supply” of possible mutations to phage is 
much less than that of bacteria. The potential for long-term coevolution is therefore 
limited by the ceiling on phage host range evolution imposed by mutational 
asymmetry.  
 
Although mutational asymmetry is probably a key constraint on bacteria-phage 
coevolution, the influence of other evolutionary and ecological forces can maintain 
bacteria-phage coevolution and coexistence. Many bacteria-phage systems show 
that host range evolution, and bacteria-phage coevolution, are not necessarily as 
limited as Lenski and Levin (1985) suggest. Prolonged periods of arms race 
coevolution (Dawkins, 1979), where bacteria evolve to become more broadly 
resistant and phage evolve to become more broadly infective (Buckling & Rainey, 
2002b, 2002a), have been observed in laboratory cultures of several species 
(Buckling & Rainey, 2002a; Mizoguchi et al., 2003; Wichman et al., 2005; Middelboe 
et al., 2009; Hall et al., 2011b; Marston et al., 2012; Paez-Espino et al., 2015), 
including E. coli B (Meyer et al., 2012).  
 
While the evidence for arms races between bacteria and phage is strong, there do 
still seem to be fundamental limits to phage host range expansion. Scanlan et al. 
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(2013) showed that, while 2 increased its host range against sympatric and 
allopatric coevolved P. fluorescens under an arms race dynamic, this did not confer 
broader infectivity against other P. fluorescens variants. This suggests that phage 
host range evolution may still constrained to their specific coevolutionary context. In 
nature, phage tend toward specialism rather than generalism (Hyman & Abedon, 
2010; Koskella & Meaden, 2013; Martiny et al., 2014). Analyses of bacteria-phage 
interaction networks, which represent and quantify the patterns of infectivity and 
resistance in a bacteria-phage community (Weitz et al., 2013), show that while 
phage can indeed occupy all parts of the specialist-generalist spectrum in nature 
(Flores et al., 2013; Poisot et al., 2013), these networks tend to have a nested 
structure, with a few common generalist and many rare specialist phage genotypes 
(Weitz et al., 2013; Martiny et al., 2014). It is interesting to consider that this pattern 
of “few common, many rare” in bacteria-phage interactions is consistent with more 
general patterns of community assembly at different ecological levels (Lawton, 1999; 
Magurran & Henderson, 2003; Verberk et al., 2010).  
 
Aside from mutational asymmetry, what other factors may limit phage host range 
expansion and favour specialism over generalism? Fitness trade-offs, where the 
evolution of a broader host range incurs the cost of losing infectivity on the original 
host, have been shown to limit host range expansion of 6 infecting P. syringae 
(Duffy et al., 2006). Further, Hall et al. (2011b) show that increasing costs of 
generalism eventually weaken the arms race dynamic between P. fluorescens and 
2. This can give way to fluctuating selection dynamics (Gandon et al., 2008) and 
increased specialisation. Fitness trade-offs and the costs of generalism may also 
scale with the diversity or heterogeneity of the host population, where losing 
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infectivity on the original host may be more likely to limit phage transmission when 
susceptible hosts are less available.  
 
Variability in host quality has also been suggested to shape phage host range 
evolution in terms of optimal foraging. Optimal foraging theory assumes that 
resources (host cells), are heterogeneous in terms of quality or spatiotemporal 
availability, and that the costs of increased host range are incurred by lost 
opportunities to exploit better-quality hosts (MacArthur & Pianka, 1966; Pyke et al., 
1977). The more likely an encounter with a lower-quality host, the more 
advantageous it is to specialise on a higher-quality host – better the devil you know. 
Optimal foraging also predicts that the degree of specialisation is dependent on host 
density. Heineman et al. (2008) showed that specialist T7 phage were selected for 
when higher-quality E. coli hosts were common, or when hosts significantly varied in 
quality, and that the degree of specialisation indeed dependent on host density. 
However, spatial heterogeneity did not lead to increased specialisation in the P. 
fluorescens-2 system (Hesse et al., 2015), which may be due to other selective 
forces imposed on the host by diverse environmental conditions. Finally, Guyader 
and Burch (2008) showed that generalist phage did not evolve toward increased 
specialisation at high host densities, and vice versa, as would be expected if optimal 
foraging shaped phage host range evolution. Together, genetic constraints in terms 
of mutational asymmetry and fitness trade-offs, rather than ecological constraints in 
terms of host resource patchiness, are likely to play a larger role in limiting phage 
host range evolution. The importance of genetic constraints, especially in diverse 
host populations, has been explored further in bacteria-phage systems where hosts 
employ a CRISPR-Cas immune system. 
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Experimental tests – CRISPR-Cas systems 
 
Most recently, there has been increasing interest in how the CRISPR-Cas bacterial 
immune system can be used to inform a more general understanding of how 
diversity shape host-pathogen ecology and evolution. CRISPR-Cas immune systems 
can incorporate short DNA fragments (spacers) of about 30 base pairs (bp) derived 
from the phage genome into CRISPR loci on the host genome (Horvath et al., 2008). 
Processed CRISPR transcripts guide Cas immune complexes to identify and cleave 
the invading phage genome, preventing successful re-infections (Brouns et al., 2008; 
Marraffini & Sontheimer, 2008; Garneau et al., 2010; Datsenko et al., 2012; Westra 
et al., 2012b). Because the process of spacer acquisition samples genetic material 
from the phage population, CRISPR-Cas can rapidly generate high levels of within- 
and between-host diversity. This has been observed by several studies in both 
natural and experimental bacteria-phage communities (Andersson & Banfield, 2008; 
Paez-Espino et al., 2013; Westra et al., 2015; Pyenson & Marraffini, 2020). The 
diversity generated by CRISPR-Cas is heritable because phage-derived spacers are 
passed to daughter cells. Although diversity is heritable, spacers at the CRISPR loci 
can be lost over time (W. Jiang et al., 2013; Chaudhry et al., 2018). Phage can 
evolve to overcome CRISPR immunity by point mutation in the sequence targeted by 
the spacer (protospacer) or in the protospacer-adjacent motif (PAM), which flanks 
the protospacer and functions in self/non self-discrimination (Deveau et al., 2008; 
Mojica et al., 2009; Semenova et al., 2011; Westra et al., 2013).  
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The mechanistic features of CRISPR-Cas and phage, as well as their coevolution, 
make it an ideal model system with which to study the evolutionary ecology of 
infectious diseases, and especially the role of host diversity. Because the molecular 
basis of host immunity and phage escape is well-understood and relatively easy to 
characterise using PCR and Sanger sequencing, phenotypic changes (host 
resistance, phage infectivity) can be linked to genotypic changes (spacer acquisition, 
protospacer evolution). Host diversity can be easily experimentally manipulated by 
mixing bacterial clones with different CRISPR loci, and is also straightforward to 
measure in downstream analyses. One of the most exciting and innovative 
applications of CRISPR-Cas to the question of host diversity is that it can used to 
generate different genetic architectures of host-pathogen resistance-infectivity that 
directly reflect the core assumptions of many mathematical models of coevolution 
(Agrawal & Lively, 2002; Lively, 2010).  
 
CRISPR diversity can provide increased resistance by limiting the ability of phage to 
acquire the mutations needed to overcome CRISPR immunity. Phage evolution can 
be limited by mutation supply, as discussed above (Lenski & Levin, 1985). Mutation 
supply in the context of CRISPR occurs because the expansion of a host’s spacer 
repertoire offers multiple mutational routes to phage resistance at little to no fitness 
cost (Vale et al., 2015), while phage are relatively more constrained by the need to 
alter targeted protospacers through SNPs or more significant mutations in order to 
evade CRISPR-Cas interference (Levin et al., 2013; Chabas et al., 2018). Further, 
full phage infectivity requires mutations in all the protospacers targeted by the host 
CRISPR array. This is similar to the suggested reason for mutational asymmetry in 
P. fluorescens and phage 2, whereby the evolution of host range expansion 
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requires the stepwise addition of mutations (Hall et al., 2011a; Hall et al., 2011b). 
This becomes more difficult as individual-and population-level CRISPR diversity 
increases (Levin et al., 2013; van Houte et al., 2016b), and can drive rapid phage 
extinction in both P. aeruginosa and S. thermophilus (van Houte et al., 2016b; 
Morley et al., 2017; Chabas et al., 2018). Finally, community diversity has been 
shown to alter the relative fitness of CRISPR-Cas compared to surface modification 
(SM), with consequences for the virulence of a mixed bacterial infection (Alseth et 
al., 2019). More specifically, understanding how ecology shapes the selective forces 
that favour different immune systems has important implications for treating clinical 
bacterial infections and optimising phage therapy (Westra et al., 2012a; van Houte et 




Although experiments using bacteria-phage as a model system have yielded many 
novel insights into the role of diversity in host-pathogen dynamics, this approach is 
inevitably associated with limitations regarding generality. Combining and 
complimenting it with theory helps to generalise e.g. Chabas et al. (2018). Moreover, 
while bacteria may seem far from eukaryotes, certain core principles are conserved. 
For example, the way in which CRISPR generates diversity in host populations is 
conceptually similar to the vertebrate immune system. The major histocompatibility 
complex (MHC) underpins the adaptive immune response in jawed vertebrates, and 
particularly so in mammals. Importantly, MHC genes are diverse: they frequently 
emerge as “hot spots” in genome-wide association studies (GWAS) in humans, and 
tend to carry on average more SNPs, indels, gene duplications, transposable 
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element insertions and inversions than the rest of the genome (Chuang & Li, 2004). 
They are also hot spots for recombination during gamete formation (Paigen & 
Petkov, 2010). The high relative diversity of MHC genes is generated by higher rates 
of germline mutagenesis and sexual reproduction. While MHC genes can generate 
high host diversity from one generation to the next, V(D)J (Variable, Joining, 
sometimes Diversity) recombination generates immense between- and within-host 
diversity in a single generation (Early et al., 1980; Rast & Litman, 1994). The V(D)J 
mechanism can generate highly-diverse repertoires of B and T cell receptors and 
antibodies (Weinstein et al., 2009; N. Jiang et al., 2011). The close analogies 
between CRISPR-Cas and vertebrate immune systems as diversity-generating 
mechanisms (DGMs) (Westra et al., 2017) highlights the wider significance of using 
bacteria-phage models to understand the role of diversity in host-pathogen systems.  
 
Aims & objectives 
 
The aim of this thesis is to contribute novel understanding of how diversity in host 
populations affects the evolution and ecology of host-pathogen interactions. In the 
next three chapters I aim to address the following questions: 
 
1. How do population bottlenecks affect bacteria-phage coexistence? 
A population bottleneck is arguably the most frequent way in which population 
diversity is reduced. They capture multiple natural and anthropogenic causes of 
diversity reduction and are a recurrent outcome of host-pathogen ecology. Despite 
their pervasiveness, there has been relatively little consideration of how bottlenecks, 
as stochastic limitations of diversity, affect host-pathogen dynamics. An objective of 
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this thesis is to use bacteria-phage to explore if and how bottlenecking limits 
bacteria-phage coexistence, particularly when hosts are able to generate immune 
diversity through the CRISPR-Cas system.  
 
2. How does host diversity affect the ability of an evolved pathogen to 
establish an epidemic? 
Host diversity can influence the evolutionary emergence of a novel pathogen, as well 
as limit the epidemic spread of existing pathogens. All of the work in this area has so 
far been limited to considering how maladapted pathogens can be “rescued” by 
evolutionary change, or descriptions of how host diversity affects epidemics. 
However, insights from host-pathogen coevolution and the evolutionary dynamics of 
human pathogens tell us that these processes are intimately related and often the 
same. A key unanswered question is: how is the spread of an evolved pathogen 
affected by host diversity? An objective of this thesis is to utilise the clear 
mechanistic understanding of CRISPR-phage coevolution to explore further the link 
between the evolutionary and ecological effects of host diversity on host-pathogen 
coexistence.  
 
3. Can coevolution enable bacteria-phage coexistence in the context of a 
diversity-generating mechanism? 
Hosts and pathogens can clearly coexist over long periods of time, and ongoing 
coevolution often explains this coexistence in many different systems. In bacteria-
phage communities where hosts use CRISPR-Cas to defend against phage, the role 
of coevolution and its dynamic is disputed. Given that CRISPR-Cas is a DGM and 
thus spontaneously generates host diversity, an objective of this thesis is explore 
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what kind of coevolutionary dynamic is possible in this context and the molecular 




Chapter 2 explores how population bottlenecking affects the population and 
evolutionary dynamics between P. aeruginosa PA14 and its lytic phage, DMS3vir. 
Phage went extinct more rapidly, and sensitive host phenotypes invaded the culture, 
as bottlenecking increased. The data suggested that increased bottlenecking limited 
phage amplification, which protected the P. aeruginosa host population. With some 
exceptions, this effect was not caused by CRISPR immunity. Controls with a 
CRISPR knockout strain showed the same phage dynamics. This suggested that the 
host benefit of bottlenecking is driven by a dilution effect that disproportionately 
affects phage. Confirming this, experiments where populations of equivalent size 
were diluted to different degrees showed qualitatively similar phage dynamics. From 
the host perspective, the dilution effect should protect sensitive hosts, hence the 
invasion of sensitive cells as bottlenecking increased. Experiments where only the 
bacterial fraction of the population was bottlenecked showed that CRISPR immunity 
was maintained. This confirmed that the protective dilution effect was removed, 
maintaining selection for phage resistance across the gradient of bottleneck size.  
 
Chapter 3 builds on Chapter 2 to further explore the dilution effect in bacteria-phage 
coevolution. Instead of population bottlenecks, this chapter explicitly examined how 
the level of CRISPR diversity in the host CRISPR-Cas system affected phage 
dynamics and evolutionary emergence, as well as host dynamics, and the fitness of 
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resistant and susceptible host genotypes. A host-pathogen system was engineered 
where each bacterial host genotype could be infected by only one phage genotype. 
Experiments using this model system explored how CRISPR diversity impacts the 
spread of phage when they can overcome a resistance allele, how immune diversity 
affects the evolution of the phage to increase its host range, and if there was 
feedback between these processes. These data showed that increasing CRISPR 
diversity benefits susceptible bacteria via a dilution effect, which limits the spread of 
the phage. This study suggests that this ecological effect impacts the evolution of 
novel phage genotypes, which then feeds back into phage population dynamics. 
 
Chapter 4 shifts focus from the mechanisms by which host diversity affects bacteria-
phage interactions, and explores the nature of the coevolutionary dynamic between 
bacteria and phage. It also utilised a different model system – Streptococcus 
thermophilus and its lytic phage 2972. Over 30 days, S. thermophilus and phage 
2972 were able to coexist for many generations. Phenotypic and genotypic analysis 
of the bacterial population showed that this coexistence was enabled by a 
coevolutionary arms race dynamic (ARD) between the host’s CRISPR-mediated 
resistance and phage infectivity. Asymmetry between phage infectivity and host 
resistance due to limitations on phage mutation supply eventually caused phage 
extinction. Together, these data show that a bacterial species with a CRISPR system 
can coexist with phage over long periods because of an ARD.  
 
Contribution of published papers 
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Chapter 2 - Common J & Westra ER (2019) “CRISPR evolution and 
bacteriophage persistence in the context of population bottlenecks” RNA 
Biology 16:4, 377-379: This study provides novel insight into how bottlenecking 
influences bacteria-phage dynamics by emphasizing the role of dilution in bacteria-
phage interactions. 
 
Chapter 3 - Common J, Walker-Sünderhauf D, van Houte S, & Westra ER (2020) 
“Diversity in CRISPR-based immunity protects susceptible genotypes by 
restricting phage spread and evolution” Journal of Evolutionary Biology 33: 
1097-1108: This study shows a clear mechanism by which host diversity can limit 
pathogen spread. Such a mechanism has not previously been shown in any 
empirical host-pathogen system.  
 
Chapter 3: Common J, Morley D, Westra ER, & van Houte S (2019) “CRISPR-
Cas immunity leads to a coevolutionary arms race between Streptococcus 
thermophilus and lytic phage” Philosophical Transactions of the Royal Society 
B: Biological Sciences 374: This study provides novel insight in the way CRISPR-
Cas systems shape the population and coevolutionary dynamics of bacteria-phage 
interactions. 
 
Statement of contributions as co-author 
 
My contributions as co-author to the published papers included in this thesis are as 
follows. For each, I acknowledge and thank the anonymous reviewers, whose 
suggestions and criticisms greatly improved the papers. 
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Chapter 2 - Common J & Westra ER (2019): I was involved in the design of 
experiments, conducted all experiments and analyses, and wrote the manuscript. 
ERW conceived of the study, co-designed experiments, and provided critical 
revisions on the manuscript.  
 
Chapter 3 - Common J, Walker-Sünderhauf D, van Houte S, & Westra ER 
(2020): I was involved in the design of experiments, conducted all experiments and 
analyses, and wrote the manuscript. DWS and SVH designed the plasmid used to 
tag strains with lacZ. ERW conceived of the study and co-designed experiments. 
DWS, SVH and ERW provided critical revisions on the manuscript. 
 
Chapter 4 - Common J, Morley D, Westra ER, & van Houte S (2019): I conducted 
all statistical and genomic analyses and carried out part of the experimental work. 
The outcome of these analyses contributed significantly to the direction and narrative 
of the paper. DM conducted part of the experiments. SVH and ERW conceived the 
study and designed experiments. All authors contributed to manuscript writing.   
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Chapter 2: CRISPR evolution and bacteriophage persistence in 




The contents of this chapter have been published as the following: 
 
Common J & Westra ER (2019) “CRISPR evolution and bacteriophage 
persistence in the context of population bottlenecks” RNA Biology 16:4, 377-
379 DOI: 10.1080/15476286.2019.1578608 
 
The main text, figures, tables, and supplemental information are those which appear 
in publication. They have been formatted according to submission requirements and 
to provide consistency throughout the thesis. Details specific to publication, such as 
funding details and data accessibility, have been excluded. Author contributions can 





Population bottlenecks often cause strong reductions in genetic diversity and alter 
population structure. In the context of host-parasite interactions, bottlenecks could in 
theory benefit either the host or the pathogen. We predicted that bottlenecking of 
bacterial populations that evolve CRISPR immunity against bacteriophages (phage) 
would benefit the pathogen, because CRISPR spacer diversity can rapidly drive 
phages extinct. To test this, we bottlenecked populations of bacteria and phage, 
tracking phage persistence and the evolution of bacterial resistance mechanisms. 
Contrary to our prediction, bottlenecking worked in the advantage of the host. With 
some exceptions, this effect was not caused by CRISPR immunity. This host benefit 
is consistent with a dilution effect disproportionately affecting phage. This study 
provides further insight into how bottlenecking influences bacteria-phage dynamics, 





Many bacteria encode CRISPR-Cas immune systems [Clustered Regularly 
Interspaced Short Palindromic Repeats, CRISPR-associated], a RNA-guided 
mechanism used to defend against phage infection (van Houte et al., 2016a). In 
response to phage infection, CRISPR-Cas immune systems can incorporate short 
DNA fragments of about 30 base pairs derived from the phage genome into CRISPR 
loci on the host genome, termed spacers (Semenova et al., 2011; Swarts et al., 
2012). Processed CRISPR transcripts form small RNAs (crRNA) that bind to 
CRISPR-associated (Cas) proteins which guide the recognition and cleavage of 
complementary nucleic acid sequences. In the case of phage infection, CRISPR-Cas 
systems can target and cleave the invading phage genome, preventing successful 
re-infections (Brouns et al., 2008; Garneau et al., 2010; Datsenko et al., 2012). 
CRISPR loci in bacterial populations are often diverse (Andersson & Banfield, 2008; 
Paez-Espino et al., 2013; Westra et al., 2015). High levels of CRISPR spacer 
diversity naturally evolve in bacterial populations with type I-F CRISPR-Cas systems 
due to primed spacer acquisition (Richter et al., 2014). Priming relies on a partial 
match between a pre-existing spacer and the phage genome (Cady & O'Toole, 
2011; Westra et al., 2015), and causes an increase in the rate of spacer acquisition. 
Increasing CRISPR diversity can contribute to synergistic host benefits and cause 
increasingly rapid phage extinction (Childs et al., 2014; van Houte et al., 2016b; 
Morley et al., 2017). 
 
The levels of genetic diversity in populations of hosts and parasites are known to 
play a key role in determining the spread and evolution of infectious diseases. For 
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example, host genetic diversity can limit the spread of pathogens [reviewed in 
(Ashby & King, 2015; Jackson et al., 2017)] whereas parasite genetic diversity can 
increase the ability of parasites to adapt to local hosts (Gandon & Michalakis, 2002). 
Population bottlenecks - characterised by sudden, often repeated and usually drastic 
reductions in population size - are common in host-pathogen populations and can 
strongly reduce their genetic diversity (Hudson et al., 1998; Bohannan & Lenski, 
2000). Bottlenecks in host-pathogen systems can be levied by clinical treatment, 
such as antibiotics (Flanagan et al., 2007); as part of the normal infection cycle of a 
pathogen [e.g. Lyme Disease (Rego et al., 2014), HIV-1 (Gijsbers et al., 2012), 
Hepatitis C virus (Bull et al., 2011), reviewed in (Gutiérrez et al., 2012)]; or sudden 
changes in the abiotic environment, such as soil structure (Torsvik & Øvreås, 2002).  
 
Bottlenecks can influence host-pathogen interactions in several ways. Bottlenecking 
can benefit the pathogen, as the reduction in host diversity increases the ability of 
pathogens to adapt to overcome host defenses (Gandon & Michalakis, 2002; 
Morgan et al., 2005; Morran et al., 2011). Conversely, bottlenecks can limit the 
spread of parasites by a dilution effect (Keesing et al., 2006; Ostfeld & Keesing, 
2012), where low host density reduces contact rate between susceptible individuals 
[e.g. (Mitchell et al., 2002; Dennehy et al., 2007; Roscher et al., 2007)], or by 
stochastic fixation of resistance alleles (Quigley et al., 2012; Gokhale et al., 2013). 
The only experimental test of bottlenecking in a bacteria-bacteriophage (phage) 
system supported a host benefit, which the authors suggest was due to highly-
frequent resistant host phenotypes being more likely to pass through successive 
bottlenecks and fix in the population (Hesse & Buckling, 2016). Dennehy et al. 2007 
also found that wildtype Pseudomonas phaselicola, which are susceptible to phage, 
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benefited from a dilution effect when in mixed cultures with a pilus mutant strain that 
prevents phage attachment. However, bottlenecking would be expected to generally 
work in the advantage of the parasite when hosts rely on a diversity-generating 
immune mechanism (Westra et al., 2017) such as CRISPR.  
 
Here we set out to explore the consequences of bottlenecking in the context of 
CRISPR using P. aeruginosa strain PA14, which has a type I-F CRISPR-Cas system 
and readily evolves CRISPR immunity against its phage DMS3vir (Richter et al., 
2014; Westra et al., 2015). Given that the benefits of CRISPR immunity can depend 
on the levels of population-level spacer diversity in a pre-immunized host population 
(van Houte et al., 2016b), we predicted that increased bottlenecking of an initially 
susceptible host population, where CRISPR diversity evolves upon phage infection, 
could cause a breakdown in host diversity, removing the synergistic benefits of 






To understand the effect of bottlenecking on host and phage population dynamics, 
we infected either the WT PA14 strain or PA14 csy3::lacZ strain, which carries an 
inactive CRISPR-Cas system (hereafter referred to as ΔCRISPR) with phage 
DMS3vir in liquid media and transferred daily into fresh medium while manipulating 
the bottleneck size by varying the dilution factor at each daily transfer from 10–2 
(weakest bottleneck) to 10–9 (strongest bottleneck). Ancestral WT PA14 carries no 
spacers targeting DMS3vir, so is sensitive to infection.  
 
Surprisingly, phage went (close to) extinct in all treatments by 5 days post-infection 
(d.p.i.), irrespective of the bottleneck strength (Fig. 2.1), and importantly CRISPR 
background had no significant effect on phage titres (F1,334 = 2.12, p = 0.15), 
although there appeared to be a transient effect at the 10-4 and 10-5 bottleneck 
treatments (see Discussion). Phage extinction risks were also almost identical 
between these host genetic backgrounds for all bottlenecks (Table A2.1). Although 
there was a significant effect of CRISPR background on host titres (F1,432 = 143.2, p 
< 0.0001), this was likely due to the transiently higher average host densities at 2 
d.p.i. in all treatments (Fig. 2.2) (see Discussion). Adjusted R2 comparisons of 
nested models showed that the effect of CRISPR background explained only 10% 
more variance than a model excluding the CRISPR background interaction. 
Otherwise, host dynamics within comparable treatments were similar in CRISPR and 
ΔCRISPR backgrounds. These data therefore suggest that CRISPR-Cas systems 
overall have a negligible and transient impact on the short-term phage population 




Figure 2.1 Phage population dynamics when both host and phage are 
bottlenecked 
Mean plaque-forming units (p.f.u.) ml–1 for the WT host (i.e. encoding a functional 
CRISPR-Cas immune system) and the ΔCRISPR strain are shown for different 
bottleneck treatments (ranging from 10-2-10-9 dilutions at each transfer, as indicated 
above each panel). The detection limit is 200 p.f.u. ml-1. Error bars correspond to 





Figure 2.2 Host population dynamics when both host and phage are 
bottlenecked 
Mean colony-forming units (c.f.u.) ml–1 for the WT host (i.e. encoding a functional 
CRISPR-Cas immune system) and the ΔCRISPR strain are shown for different 
bottleneck treatments (ranging from 10-2-10-9 dilutions at each transfer, as indicated 
above each panel). The detection limit is 200 c.f.u. ml-1. Error bars correspond to 
95% confidence intervals (CIs). N = 6 for all treatments. 
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Although the presence or absence of a functional CRISPR-Cas system did not have 
a strong impact on the phage population dynamics, the bottlenecking regime itself 
did have a clear impact with stronger bottlenecks being associated with a more rapid 
decline in phage titers. This is supported by a control without phage, which shows 
that host densities remain relatively stable through all but the strongest bottleneck 
treatments (Figure A2.1). We also ruled out any abiotic effects of fresh media that 
may have disproportionately impacted phage survival [(Jończyk et al., 2011); Figure 
A2.2]. We hypothesized this might be caused by a dilution effect, i.e. a decrease in 
host densities resulting in reduced parasite spread. To explicitly test this, we first 
selected two bottleneck treatments (10–4 and 10–6) that showed clear differences in 
phage titers over time. We then set up an experiment as described above with WT 
PA14 and DMS3vir, and at 1 d.p.i. diluted the culture 100-fold and transferred daily 
0.6µl into either 6ml or 600ml of fresh media, generating either 10–4 or 10–6 dilutions 
while maintaining the same degree of bottlenecking on the population. We found that 
the small and large dilutions of bacterial populations led to a qualitatively similar 
phage population dynamics as those associated with the 10–4 and 10–6 bottleneck 
treatments, respectively (Fig. 2.3). Phage persisted in most small dilution replicates 
until 4 d.p.i, while in the large dilution it was driven extinct in all but one replicate by 3 
d.p.i. Host persisted for the duration of the experiment in the small dilution treatment, 
but were undetectable in 5 out of 6 large dilution replicates by 3 d.p.i., and in 3 out of 
6 replicates of the 10–6 bottleneck treatment, also by 3 d.p.i. These data therefore 
support the conclusion that phage population dynamics observed in the bottleneck 
experiment were driven primarily by dilution of the phage. Interestingly, phage titre 
did not covary significantly with host density in the bottleneck (F68,247 = 1.06, p = 




Figure 2.3 Phage and host dynamics when both WT host and phage are diluted 
or bottlenecked 
A 10-4 or 10-6 bottleneck corresponds to either 0.6µl or 0.006µl culture, respectively, 
in 6ml of fresh media at each transfer. A 10–4 dilution corresponds to 0.6µl culture in 
6 ml at each transfer, and a 10-6 dilution corresponds to 0.6µl culture in 600 ml at 
each transfer (see Materials & Methods). Mean plaque-forming units (p.f.u.) ml–1 and 
colony-forming units (c.f.u.) for the dilution and comparable bottleneck treatments 
are shown. The detection limit is 200 p.f.u. or c.f.u. ml-1. Error bars correspond to 
95% confidence intervals (CIs). N = 6 for all treatments. 
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dynamics are not correlated with those of the host, and consequently are likely more 
negatively affected by bottlenecking than the host.  
 
Given the observed effect of bottlenecking on the phage population dynamics, we 
investigated whether this could have knock-on effects for the evolution of host 
resistance to the phage, and the mechanistic basis for resistance evolution. For 
consistency with previous studies (Westra et al., 2015), we examined the phage 
resistance phenotypes at 3 d.p.i. Hosts with CRISPR immunity were most frequent in 
the 10-2 – 10-5 bottleneck treatments, which all contained detectable levels of phage 
at 3 d.p.i. However, bottlenecks of 10–6 – 10-9 contained mostly sensitive hosts 
(Fig. 2.4A & Table A2.2), which we hypothesized was due to the lower levels of 
phage in those treatments. A qualitatively similar pattern in the evolution of immune 
phenotypes was observed in the dilution experiment (Figure A2.3 & Table A2.4). 
This shift from CRISPR immunity to sensitive bacteria was therefore potentially due 
to relaxed selection for host immunity as a result of phage dilution. To test this idea, 
we performed a similar experiment where we bottlenecked cultures (both WT and 
the ΔCRISPR strain) in the same way as described above but with a fixed dilution of 
10-2 for the phage. This experimental design therefore results in bottlenecking and 
dilution of the hosts while maintaining a similar phage pressure across the bottleneck 
treatments. Under these conditions, CRISPR immunity was maintained across the 
range of treatments and there was no invasion of sensitives (Fig. 2.4B & Table 
A2.3). There was again no significant covariance between phage titre and host 
density in this control (F65,250 = 1.23, p = 0.14), so that even when phage levels were 
maintained through each bottleneck, host and phage dynamics were not correlated. 
Although sensitive invasion did not occur in a ΔCRISPR background when phage 
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were supplemented, intriguingly there was also no sensitive invasion when both host 







Figure 2.4 Evolution of host resistance of the WT strain 
Relative frequencies of bacterial clones with CRISPR immunity, surface mutation 
(SM) resistance, or sensitive phenotypes, at 3 days post-infection when A) both host 
and phage were bottlenecked by dilution into fresh medium as indicated on the x-
axis s and B) host was bottlenecked by dilution into fresh medium as indicated on 
the x-axis and phage was bottlenecked at a fixed 10-2 dilution at each transfer. Error 
bars correspond to 95% confidence intervals (CIs) of the mean. N=72 for the 10-6 
treatment in panel A, and N=48 for the 10-8 treatment in panel B. No bacterial cells 
were recovered from any replicate in the 10-9 treatment in panel B. N =144 for all 




Population bottlenecks often cause strong reductions in genetic diversity (Hudson et 
al., 1998). In the context of host-parasite interactions, bottlenecks can in theory 
benefit either the host (Quigley et al., 2012; Gokhale et al., 2013) or the pathogen 
(Gandon & Michalakis, 2002; Morgan et al., 2005; Morran et al., 2011) by affecting 
host-pathogen coevolution. Bottlenecks may also benefit the host through a dilution 
effect (Keesing et al., 2006; Ostfeld & Keesing, 2012). While there is limited 
empirical support for a dilution effect in a bacteria-phage system (Dennehy et al., 
2007), and that bottlenecking benefits bacterial hosts (Hesse & Buckling, 2016), we 
predicted that bottlenecking of bacterial populations that evolve CRISPR immunity 
against phages would benefit the pathogen (Westra et al., 2017), because CRISPR 
spacer diversity can rapidly drive phages extinct (van Houte et al., 2016b).  
 
In contrast to our predictions, bottlenecking did not provide a clear advantage to the 
phage. Instead, phage were always driven extinct by 5 d.p.i. irrespective of the 
degree of population bottlenecking. Surprisingly, this effect was not CRISPR-specific 
but seemed to be driven instead by bottlenecking per se, as suggested by similar 
phage dynamics in the context of a CRISPR-knockout strain. Exploring the potential 
role of a dilution effect through bottlenecking, we found that dilution alone is sufficient 
to drive phage extinct in a CRISPR background. In support of this, phage density 
was uncoupled from host density in all experiments and phage extinction was more 
rapid after 10–6 bottlenecks in cultures with surviving host. Both findings are 
consistent with dilution disproportionately affecting phage. This biased effect on 
phage may be related to the different resource requirements of bacteria and phage. 
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After passing through even very small bottlenecks, bacterial cells can still replicate if 
environmental resources are available. By contrast, phage cannot replicate 
independent of hosts - they require a sufficient number and density of host cells to 
recover after a bottleneck has been applied. Such an imbalance in resource 
dependence between bacteria and phage, coupled with a reduction in numbers of 
individual hosts, might explain why phage were more susceptible to dilution. While 
dilution of hosts can suppress phage epidemics, this will quantitatively depend on 
phage life history traits, such as adsorption rates, latent period and burst size of the 
phages. It would be interesting therefore to further explore how these factors affect 
phage persistence and evolution in the context of host dilution.  
 
From the perspective of the bacterial host, a dilution effect relaxed selection for 
CRISPR immunity and allowed sensitive hosts to invade, particularly in the stronger 
bottleneck treatments of 10–6 and above. However, we did not see a similar invasion 
of sensitives in the ΔCRISPR background. It is unclear why sensitives did not 
invade, but we speculate that it might be attributable to either hosts with CRISPR 
immunity losing their resistance (Chaudhry et al., 2018; Weissman et al., 2018a), or 
the CRISPR fraction of the host population ‘protecting’ sensitive hosts at the start of 
an infection (Payne et al., 2018), allowing them to invade after already dilute phage 
have been cleared. When phage were supplemented, sensitives could not invade 
and CRISPR immunity was most relatively frequent.  
 
Finally, although our results are generally consistent with a dilution being the most 
important determinant of the phage population dynamics, we did detect some 
transient effects which are likely driven by CRISPR immunity. First, transiently higher 
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average host densities at 2 d.p.i. in all treatments (Fig. 2.2) may be due to a 
difference in how quickly hosts with CRISPR immunity versus surface modification 
(SM) invade the culture. Second, in the experiment where only the host was 
bottlenecked (resulting in high levels of CRISPR resistance evolution at all 
treatments), phage titres were statistically similar across bottleneck treatments at all 
timepoints for the WT bacteria with functional CRISPR-Cas (Figure A2.5A), but not 
for the ΔCRISPR bacteria (Figure A2.5B). Third, in the experiment where the whole 
culture was bottlenecked, phage titres in the 10–4 and 10–5 treatments were 
consistently significantly higher at most timepoints compared to the ΔCRISPR 
background (Fig. 2.1), supported by a one-way ANOVA of the effect of host 
background on phage titre across the whole 6-point time series (F1,36 = 8.92, p < 
0.01). These phage titres were maintained despite 10,000- and 100,000-fold 
reductions of phage immediately after the bottlenecking had been applied, 
suggesting that phage were still able to successfully amplify on sensitive hosts. High 
phage titres in these treatments occurred in the context of high relative frequency of 
CRISPR immunity in the host, raising the possibility of an interaction between 
CRISPR, host density, and bottlenecking of a certain degree that appears to 
temporarily favour phage. This suggests that within a certain range of bottleneck 
treatments CRISPR defenses may become less effective in driving phages extinct, 
either because of population dynamics or evolutionary effects, or both. 
 
Altogether, this study provides further insight into how bottlenecking influences 
bacteria-phage dynamics and the evolution of host resistance. Bottlenecking does 
impact the ability of phage to coexist with the host, but this is generally independent 
of whether or not the host has a functional CRISPR-Cas immune system. Instead, 
 50 
our findings support the role of a dilution effect caused by bottlenecking that 
disproportionately affects phage titre and survival. However, we also find some 
CRISPR-specific effects under certain conditions that may be related to a complex 
interaction between host immune systems and host-pathogen dynamics.   
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Materials & Methods 
 
Bacterial strains & phage 
 
The bacterial strains and phages used in this study have all been described 
previously. Evolution experiments were carried out using Pseudomonas aeruginosa 
UCBPP-PA14 (WT) and phage DMS3vir (Cady et al., 2012). We used P. 
aeuruginosa UCBPP-PA14 csy3::lacZ (Zegans et al., 2009) in CRISPR-negative 
control experiments and streak assays, and DMS3vir-AcrF1 (van Houte et al., 




All experiments were established in glass vials by inoculating 6ml of M9 minimal 
media (supplemented with 0.2% glucose) with ~1x106 c.f.u. (colony-forming units) 
from an overnight culture of WT P. aeruginosa PA14. Approximately 1x104 
p.f.u. (plaque-forming units) of DMS3vir was added to each glass vial. A phage-
negative control was established similarly but without the addition of phage. A 
CRISPR-negative control was also established by inoculating 6ml of M9 minimal 
media with ~1x106 c.f.u. of P. aeruginosa PA14 csy3::lacZ and ~1x104 of DMS3vir. 
At this point (0 d.p.i.), 180μl of culture was taken from each vial and phage was 
extracted using chloroform. To determine phage titres, extracted phage was then 
serially diluted eight times in 96-well plates, and 5μl of each phage dilution was 
spotted on a top lawn of P. aeruginosa PA14 csy3::lacZ. The detection limit of phage 
spot assays is 102 p.f.u. ml–1. Samples of culture were serially diluted in M9 minimal 
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media, plated on LB agar and incubated overnight at 37˚C. C.f.u.s were counted to 
determine host densities. The vials were then incubated at 37˚C while shaking at 
180rpm.  
 
After 24hrs of growth (1 d.p.i.) the phage and host sampling protocol, described 
above, was repeated. To generate bottleneck treatments, samples of culture were 
then serially diluted in M9 minimal media from 10–1, 10–2, …10–7. 60μl from undiluted 
culture and each dilution were then used to inoculate 6ml of fresh M9 minimal media. 
This method of dilution and transfer gives eight bottleneck treatments of 10–2, 10–3, 
…10–9. To ensure only the host was bottlenecked in the phage-supplemented 
control, we added 60μl of chloroform-extracted phage from the corresponding 
replicate into each inoculated microcosm. Each bottleneck was performed in six 
independent replicates (N = 6). Host and phage sampling, as well as the 
bottlenecking procedure in each treatment, was repeated 24hrs after growth in fresh 




We explicitly tested the effect of culture dilution on population dynamics and 
immunity evolution. Twelve glass vials with 6ml M9 minimal media were established 
with WT P. aeruginosa PA14 and DMS3vir as described above, and the host and 
phage were assayed. We then established two dilution treatments that corresponded 
to the 10–4 and 10–6 bottleneck treatments, treatments which showed clear 
differences in phage titers over time. At 1 d.p.i., all twelve cultures were serially 
diluted. Six vials (N = 6) of 6ml M9 minimal media were inoculated with 60μl of the 
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10–2 dilution (0.0006ml/6ml = 1x10–4). Six bottles (N = 6) of 600ml M9 minimal media 
were also inoculated with 60μl of the 10–2 dilution (0.0006ml/600ml = 1x10–6). 
Sampling (as described above) and dilution were repeated 24hrs after growth in 
fresh medium until 5 d.p.i. Samples of the culture were taken prior to dilution. 
 
Determining host immune phenotype 
 
Bacterial immunity against ancestral phage was determined at 3 d.p.i, using two 
independent assays as described in Westra et al. (2015). First, bacteria were plated 
on LB-agar, and 24 randomly-selected individual clones per replicate were streaked 
through either DMS3vir or DMS3vir-AcrIF1, which encodes an anti-CRISPR gene. 
Clones sensitive to both phage genotypes were scored as ‘sensitive’; those resistant 
to the DMS3vir but sensitive to DMS3vir-AcrIF1 were scored as ‘CRISPR resistant’; 
and those resistant to both were scored as ‘surface mutant (SM)’. Second, each 
clone was also grown for 24hrs in M9 media in the presence or absence of DMS3vir, 





All statistical analyses were conducted in R (R Core Team, 2018). We took a nested 
Generalized Linear Model (GLM) approach, and model selection was performed 
using Aikaike’s Information Criteria (AIC) (Akaike, 1973; Burnham & Anderson, 
2004). Models of phage titre and host densities used log-transformed residuals to fit 
the assumption of normality, and coefficients were back-transformed prior to 
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presentation. Models of phenotype relative frequency used a binomial family with a 
logit link, and logit coefficients were back-transformed to probability values. We used 
a Cox proportional hazards model to assess the effect of bottleneck size on phage 
survivorship over the course of an experiment, with hazard ratio coefficients 
expressing the relative risk of phage extinction over time. ‘Bottleneck’ was treated as 
a discrete variable in all models. The package ggplot2 was used to generate 
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the draft of the paper.  
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Chapter 3: Diversity in CRISPR-based immunity protects 
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Diversity in host resistance often associates with reduced pathogen spread. This 
may result from ecological and evolutionary processes, likely with feedback between 
them. Theory and experiments on bacteria-phage interactions have shown that 
genetic diversity of the bacterial adaptive immune system can limit phage evolution 
to overcome resistance. Using the CRISPR-Cas bacterial immune system and lytic 
phage, we engineered a host-pathogen system where each bacterial host genotype 
could be infected by only one phage genotype. With this model system, we explored 
how CRISPR diversity impacts the spread of phage when they can overcome a 
resistance allele, how immune diversity affects the evolution of the phage to increase 
its host range, and if there was feedback between these processes. We show that 
increasing CRISPR diversity benefits susceptible bacteria via a dilution effect, which 
limits the spread of the phage. We suggest that this ecological effect impacts the 





Genetic diversity is a key determinant of the ecology and evolution of host-pathogen 
systems. Various studies of wild organisms have shown that genetic diversity within 
a host species often affects pathogen prevalence. The importance of diversity for 
disease prevalence in wild populations has been observed in numerous species, for 
example: cheetahs (O'Brien et al., 1985); Italian agile frogs (Pearman & Garner, 
2005); crimson rosella parrots (Eastwood et al., 2017); inbred black-footed ferret 
populations (Thorne & Williams, 1988); inbred California sea lions (Acevedo-
Whitehouse et al., 2003); young island populations of deer mice (Meagher, 1999); 
and Galapagos hawks (Whiteman et al., 2007). The importance of diversity for 
limiting disease in agricultural contexts has long been recognised (Elton, 1958), for 
example in rice (Zhu et al., 2000) and hybridising populations of honeybees (López-
Uribe et al., 2017). In laboratory environments, more genetically diverse populations 
of Daphnia magna are more resistant to parasites (Altermatt & Ebert, 2008), an 
effect that depends on the genetic architecture of resistance (Luijckx et al., 2013). In 
microbial systems, Pseudomonas aeruginosa PA14 and Streptococcus thermophilus 
with diverse immunity alleles were shown to be more resistant against lytic 
bacteriophage (van Houte et al., 2016b; Morley et al., 2017). Two recent meta-
analyses have shown that host diversity is a robust defence against pathogens both 
in agricultural (Reiss & Drinkwater, 2018) and natural populations (Ekroth et al., 
2019). 
 
The suggested reasons for the effect of host diversity on pathogen spread can be 
broadly divided into ecological and evolutionary effects. The ecological effect of 
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diversity may manifest through a dilution effect (Ostfeld & Keesing, 2012; Civitello et 
al., 2015). The dilution effect, in terms of within-species immune diversity, is 
suggested to arise because increasing the number of resistant or low-quality 
individuals in a host population decreases the proportion of susceptible individuals in 
that population. This can reduce contact rates between free-living pathogens and 
susceptible hosts, which in turn limits the basic reproduction number of the pathogen 
(R0) (Dobson, 2004; Gandon, 2004; Lively, 2010). There is much observational 
support for the role of a dilution effect in multi-species host-pathogen systems 
[reviewed in Civitello et al., (2015)], and some experimental work has suggested that 
dilution of susceptible host genotypes can limit pathogen spread in single host 
species systems (Dennehy et al., 2007; Common & Westra, 2019). Evolutionary 
effects of diversity may manifest through limitation of the evolutionary emergence of 
novel pathogen genotypes (Sasaki, 2000; Ohtsuki & Sasaki, 2006). Importantly 
though, the evolutionary and ecological effects of host diversity are interdependent 
as the basic reproductive value of a pathogen will influence its ability to evolve to 
overcome host resistance (Antia et al., 2003). Because increasing host diversity 
dilutes susceptible hosts, pathogens may reach smaller population sizes and 
generate fewer novel variants on which selection can act (Antia et al., 2003; 
Dennehy et al., 2006; Yates et al., 2006). Simultaneously, increasing host diversity 
can increase selection for novel variants. These two effects can maximise 
evolutionary emergence at intermediate host diversity (Benmayor et al., 2009; 
Chabas et al., 2018).  
 
The interaction between lytic bacteriophage (phage) and the bacterial CRISPR-Cas 
(Clustered Regularly Interspaced Short Palindromic Repeats; CRISPR-associated) 
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immune system is a tractable model system to study the evolutionary ecology of 
infectious diseases, including the role of host diversity (van Houte et al., 2016b; 
Westra et al., 2017; Chabas et al., 2018). CRISPR-Cas immune systems can 
incorporate short DNA fragments (spacers) of about 30 base pairs derived from the 
phage genome into CRISPR loci on the host genome (Horvath et al., 2008). 
Processed CRISPR transcripts guide Cas immune complexes to identify and cleave 
the invading phage genome, preventing successful re-infections (Brouns et al., 2008; 
Marraffini & Sontheimer, 2008; Garneau et al., 2010; Datsenko et al., 2012; Westra 
et al., 2012b). In turn, phage can evolve to overcome CRISPR immunity by point 
mutation in the sequence targeted by the spacer (protospacer) or in the protospacer-
adjacent motif (PAM), which flanks the protospacer and functions in self/non-self 
discrimination (Deveau et al., 2008; Mojica et al., 2009; Semenova et al., 2011; 
Westra et al., 2013). Phage evolution to overcome CRISPR immunity can lead to 
CRISPR-phage coevolution (Paez-Espino et al., 2013; Paez-Espino et al., 2015; Sun 
et al., 2016; Common et al., 2019). CRISPR loci in both natural and experimental 
populations can be highly diverse (Andersson & Banfield, 2008; Paez-Espino et al., 
2013; Westra et al., 2015; Common et al., 2019), due to different bacteria in the 
population acquiring different spacers (Westra et al., 2017). Diversity has important 
implications for the coevolutionary interaction, as CRISPR diversity can provide 
increased resistance by limiting the ability of phage to acquire the mutations needed 
to overcome CRISPR immunity (van Houte et al., 2016b; Morley et al., 2017; 
Common et al., 2019). Phage mutation is limited by mutation supply (Lenski & Levin, 
1985; Levin et al., 2013; Chabas et al., 2018), and full phage infectivity requires 
mutations in all the protospacers targeted by the host CRISPR array. This becomes 
more difficult as individual-and population-level CRISPR diversity increases (Levin et 
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al., 2013; van Houte et al., 2016b), and can drive rapid phage extinction (van Houte 
et al., 2016b; Morley et al., 2017; Chabas et al., 2018). 
 
Apart from this evolutionary effect, theory predicts that even if a phage mutant 
evolved that can overcome one CRISPR resistance allele in the population, its ability 
to amplify will be reduced in a more diverse host population (Lively, 2010). The 
resulting smaller phage population sizes are in turn predicted to reduce the ability of 
the phage to evolve to overcome other CRISPR resistance alleles in the population 
(Antia et al., 2003; Chabas et al., 2018). However, these predictions remain 
untested. We therefore set out to explicitly test how host diversity could limit 
pathogen population size through a dilution effect, if and how this affects phage 
evolution, and the degree of interdependence between these processes. Using the 
bacteria Pseudomonas aeruginosa and its lytic phage DMS3vir, we performed an 
experiment where we manipulated the degree of CRISPR diversity in the host 
population by mixing bacterial genotypes that each carried a different CRISPR 
spacer. We then infected these host populations with a phage that was pre-evolved 
to infect only one host genotype. We then tracked changes in host fitness, and 




To explore how population-level immune diversity would influence the population 
dynamics and evolution of an infective phage and its susceptible host genotype, we 
first developed a library of 24 P. aeruginosa PA14 bacteriophage-insensitive mutants 
(BIMs), and a corresponding library of 24 DMS3vir mutants, each of which was pre-
evolved to infect only one of the 24 host BIMs (escape phage; Fig. 3.1A). We then 
set up an experiment where we mixed 1, 3, 6, 12 or 24 BIMs, and inoculated each 
mixture with ~106 pfu ml-1 of a single escape phage (Fig. 3.1B). Because this 
experimental design increases the proportion of resistant bacterial hosts while 
decreasing the proportion of the susceptible host (i.e. the one that could be infected 
by the escape phage) (Figure A3.1), it enables us to explicitly test how this dilution 
effect is related to the benefits of host CRISPR allele diversity. The susceptible clone 
always carried a lacZ reporter gene, so we could follow its population dynamics and 
competitive performance during the experiment (Fig. 3.1B).  P. aeruginosa ∆pilA, an 
isogenic mutant which does not have CRISPR immunity and resists phage infection 
via surface receptor modification, was added to each host mixture (Fig. 3.1B). P. 
aeruginosa ∆pilA was resistant to all phage, and allowed us to compare the fitness of 
the CRISPR immune populations across the CRISPR allele diversity levels. We also 
included 1- and 24-clone treatments inoculated with ancestral phage to which the 
whole bacterial population was resistant. These treatments allowed us to examine 
bacteria and phage dynamics at the two extremes of host diversity we tested in host 
populations with no pre-existing susceptibility. We then compared those dynamics 
with host mixtures that included a susceptible clone (van Houte et al., 2016b)(Fig. 




Figure 3.1 Experimental design 
(A) Infectivity matrix of the library of bacteriophage-insensitive mutants (BIMs) and 
escape phages. The identity of BIMs and escape phage (1-24) are shown in the first 
row and column, respectively. Black squares represent infectivity, white indicates no 
infectivity. Infectivity of the wild-type DMS3vir is shown, as well as the infectivity of  
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(Figure 3.1 caption contd.) 
each escape phage on wild-type P. aeruginosa PA14. (B) Design of the co-culture 
experiment. The library of BIMs and escape phage is shown at the top. For each 
CRISPR allele diversity treatment, the relevant numbers of BIMs and escape phage 
were taken from the library and used to start the experiment, as shown by the arrows. 
The number of BIMs is shown next to the arrows. Blue text indicates that the BIM was 
engineered to carry a lacZ reporter gene, and that it was susceptible to the escape 
phage. Black text indicates that the BIMs were resistant to the phage. The number of 
replicates (N) is given underneath each treatment. SM represents the surface mutant 
strain PA14 ∆pilA. 
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clones with CRISPR immunity, and the susceptible fraction of the CRISPR 
population over 3 days. 
 
We hypothesised that if CRISPR diversity limits phage epidemics, then phage 
density would be negatively correlated with CRISPR diversity. Phage densities 
decreased as CRISPR diversity increased (F6,342 = 48.30, p < 2.2 x 10-16; Fig. 3.2), 
phage population sizes decreased over the course of the experiment (regression of 
ln plaque-forming units [pfu] ml-1 over days post-infection [dpi]:   [95% CI] = -1.32 [-
1.74, -0.94], t(2)344 = -6.40, p = 5.06 x 10-10), and phage declined faster with 
increasing CRISPR diversity (interaction between CRISPR diversity and days post-
infection: F6,314 = 24.10, p < 2.2 x 10-16; Fig. 3.2A & B). This is consistent with an 
effect of CRISPR diversity that protects the bacterial population from phage. Further, 
phage titre in the 1-clone treatment infected with ancestral phage [“1-clone 
(ancestral)” in Fig. 3.2B] is statistically similar to that observed in the 1-clone 
treatment infected with an escape phage [“Intercept” in Fig. 3.2B], which is in line 
with previous data showing that monocultures composed of hosts with CRISPR 
immunity allow phage persistence due to rapid evolution of escape phage that 
overcome the CRISPR resistance allele (van Houte et al., 2016b). The evolution of 
escape phage in our monoculture treatments likely caused the observed fluctuations 
in the density of hosts with CRISPR immunity (Figure A3.1). When we explored the 
model further, we found that phage titres in the 24-clone (ancestral phage) treatment 
were lower than the 24-clone treatment infected with escape phage (difference in ln 
pfu ml-1:   [95% CI] = -2.40 [-4.67, -0.33], t(2)342 = -2.25, p = 0.03; Fig. 3.2B). This is 




Figure 3.2. Increasing CRISPR diversity limited phage population size 
(A) Population dynamics of phage at different levels of CRISPR diversity in the host 
population (panels). Black lines show the phage density expressed as plaque-forming 
units (pfu) ml-1 in individual replicates at each day post-infection. The limit of phage  
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(Figure 3.2 caption contd.) 
detection is 200 pfu ml-1. (B) Coefficients from a GLMM of the natural log of phage 
density (ln[pfu ml-1]), with CRISPR allele diversity treatment and days post-infection 
(dpi) as fixed effects. The intercept is the mean phage titre in the 1-clone treatment at 
0 dpi. The  differences from the intercept (shown as a dotted line) are given for the 
remaining levels of both fixed effects. Means are shown as white points with 67, 89% 
and 95% credibility intervals given in decreasing width. 
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susceptible fraction of the host population in the 24-clone treatment infected with 
escape phage. 
 
Next, we hypothesised that if phage population size across our CRISPR diversity 
treatments was related to phage evolution, the proportion of phage that evolved an 
expanded infectivity range would correlate with CRISPR diversity. Given that our 
experiment was designed such that the proportion of the host population resistant to 
the escape phage increased with CRISPR diversity, there would likely have been 
strong selection to acquire mutations in other protospacers and PAMs to infect other 
hosts in the population. The evolution of range expansion did depend on diversity 
(Likelihood Ratio = 6.60, p = 0.01), and was most likely in the 6-clone treatment, 
particularly at 3 days post-infection (dpi) (Fig. 3.3). This result suggests that 
intermediate host diversity in the 6-clone treatment increased the likelihood that 
novel escape phage with an expanded host range would evolve (Benmayor et al., 
2009; Chabas et al., 2018). The fact that these novel phage could infect more hosts 
likely explains why phage population size was more consistent in the 6-clone 
compared to the 3-clone treatment (Fig. 3.2A), and there was no significant 
difference in phage population size between these treatments (Fig. 3.2B). Together, 
these data suggest that the increased likelihood of evolutionary emergence at 
intermediate host diversity balances against the potential limitation of reproduction 
caused by the dilution effect. These novel phage variants could then maintain phage 
population size. 
 
Additionally, the presence of phage in some treatments was promoted by evolution 
of a host shift, where infectivity on the original host is lost but phage evolved to infect  
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Figure 3.3 Phage evolutionary emergence was maximised at intermediate 
CRISPR diversity  
Estimated proportion of phage that had evolved to infect a second CRISPR clone in 
addition to the original CRISPR clone they were pre-evolved to infect at each day post-
infection in each polyclonal CRISPR diversity treatment. Because these estimates are 
derived from a Bayesian GLMM, they are posterior modes - not means – and are 
shown as white points. Similarly, 67, 89 and 95% credibility intervals are highest 
probability density intervals, and are given in decreasing width around mode 
estimates. Raw values from each replicate are shown as points.    
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a new host. This is a less likely event as it involves two mutations: back-mutation to 
the ancestral state at the original protospacer followed by mutation at the new 
protospacer, all while incurring the cost of loss of infectivity on the original host. We 
observed phage in two out of eight replicates of the 24-clone treatment had evolved 
a host shift. Sequence data confirmed that single nucleotide polymorphisms (SNPs) 
in the PAM that conferred infectivity to the original host had been lost, and novel 
SNPs or deletions had emerged in protospacers that conferred infectivity to a new 
host present in the population (Tables A3.4 & A3.5). Recall that phage titres in the 
24-clone (ancestral phage) treatment were lower than the 24-clone treatment 
infected with escape phage (Fig. 3.2B). Together with the presence of phage that 
evolved by host shift, these data suggest that the establishment of a modest phage 
epidemic in this treatment may have facilitated the evolutionary emergence of novel 
phage. 
 
Given that CRISPR diversity negatively affected phage population size, we expected 
that this would lead to enhanced fitness of all bacterial hosts with CRISPR immunity  
relative to hosts without CRISPR immunity (van Houte et al., 2016b). This is because 
the fitness costs associated with CRISPR immunity are conditional upon phage 
exposure (Westra et al., 2015). We therefore hypothesised that the selection rate 
(Lenski, 1991; Travisano & Lenski, 1996) of all CRISPR clones (both resistant and 
susceptible) compared to the ∆pilA strain (which does not use CRISPR immunity) 
would be positively related to CRISPR diversity. Despite some variation among 
replicates, we did find that CRISPR clones in all polyclonal host populations had 
higher selection rates compared to clonal populations during infection with escape 
phage (Figs. 3.4A & B). In 3, 3, and 4 replicates in the 12-, 24-, and 24-clone 
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(ancestral phage) treatments, respectively, the density of the ∆pilA strain dropped to 
zero (Figure A3.1), suggesting that hosts with CRISPR immunity could occasionally 
outcompete those without. However, the selection rate of hosts with CRISPR 
immunity did not differ among the polyclonal treatments (F4,113 = 1.73, p = 0.15; Fig. 
3.4C). Selection rate also did not change notably over time (regression of selection 
rate over dpi:   [95% CI] = 0.03 [-0.04, 0.11], t(2)118 = 0.94, p = 0.35) even though 
phage densities decreased with time.   
 
The absence of a detectable relationship between the level of CRISPR diversity and 
the selection rate of hosts with CRISPR immunity relative to those without might be 
because escape phage dynamics were dependent on proportion of sensitive bacteria 
in the host population. We hypothesised that the selection rate of susceptible 
CRISPR clones relative to resistant CRISPR clones would be positively related to 
the level of CRISPR diversity, because the relative frequency of sensitive hosts 
declines as CRISPR diversity increases. Indeed, in some replicates in the 3- and 6-
clone treatments the selection rate of the susceptible CRISPR clone was <-6, 
indicating that they were driven extinct by phage (Fig. 3.5A). Further, the selection 
rate of susceptible CRISPR clones in these treatments was on average less than 
zero (mean selection rate [95% CI]; 3-clone:  -1.53 [-2.61, -0.45]; 6-clone: -0.99 [-
2.07, -0.09]), indicating they tended to be outcompeted by resistant CRISPR clones. 
Turning to the 12- and 24-clone treatments, the selection rate of susceptible clones 
was statistically similar to zero (12-clone: 0.12 [-0.96, 1.21]; 24-clone: 0.15 [-0.93, 
1.24]; Fig. 3.5B & C), and higher than the 3- and 6-clone treatments (Fig. 3.5B & C). 
Together, these data show that the selection rate of susceptible CRISPR clones 
increased with CRISPR diversity. There was also an increase in selection rate of 
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susceptible CRISPR clones over time among polyclonal treatments (regression of 
selection rate over dpi:   [95% CI] = 0.41 [0.03, 0.80], t(2)118 = 2.17, p = 0.03; Fig. 
3.5A & B), which parallels the decline in phage population sizes over time in the 
same treatments (regression of ln pfu ml-1 over dpi:   [95% CI] = -2.58 [-3.23, -1.84], 
t(2)114 = -7.64, p = 7.27 x 10-12). These data suggest that susceptible hosts are 
protected by population-level CRISPR diversity, and that this protection is mediated 
by a reduced ability of phage to replicate on increasingly dilute susceptible hosts 




Figure 3.4 Selection rate of bacterial hosts with CRISPR immunity did not 
increase with CRISPR diversity in polyclonal treatments 
Selection rate of hosts with CRISPR immunity relative to a strain without CRISPR 
immunity in (A) the 1-clone CRISPR diversity treatments with infective and ancestral 
phage and (B) the remaining CRISPR diversity treatments. Days post-infection is 
indicated by colour. Selection rate is the natural log of the relative change in density 
of bacteria with CRISPR immunity (both susceptible and resistant to phage) against a 
strain without. The dotted line at zero indicates no difference in density change i.e. 
both are equally fit. Boxplots show the median, 25th and 75th percentile, and the 
interquartile range. Raw values from each replicate are shown as points. (C) Predicted 
mean selection rate is calculated from a GLMM that statistically controls for the effect 
of time. Means are shown as white points with 67, 89 and 95% credibility intervals 
given in decreasing width. 
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Figure 3.5 The selection rate of susceptible CRISPR clones increased with 
CRISPR diversity and over time 
Selection rate of the susceptible CRISPR clones relative to the resistant CRISPR 
clones in (A) the 3- and 6-clone CRISPR diversity treatments and (B) the remaining 
CRISPR diversity treatments. Days post-infection is indicated by colour. Selection 
rate is the natural log of the relative change in density of CRISPR clones that were 
susceptible to phage against CRISPR clones that were resistant to phage. The 
dotted line at zero indicates no difference in density change i.e. both are equally fit. 
Boxplots show the median, 25th and 75th percentile, and the interquartile range. Raw 
values from each replicate are shown as points. The 1-clone treatments, both with 
infective and ancestral phage, have been excluded because all bacterial clones with 
CRISPR-based resistance in this treatment were susceptible, and the data is 
therefore present in Fig. 4A. (C) Predicted mean selection rate is calculated from a  
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(Figure 3.5 caption contd.) 
GLMM that statistically controls for the effect of time. Means are shown as white 




Previous studies have shown that CRISPR diversity can limit the evolution of phage 
to overcome host resistance (van Houte et al., 2016b; Chabas et al., 2018). In those 
studies, bacterial populations were infected with ancestral phage that had not been 
previously exposed to resistant hosts. Here, we examined the consequences of 
CRISPR diversity once a phage has already evolved to overcome one of the 
CRISPR resistance alleles in the population. This tractable system enabled us to 
closely monitor how the level of CRISPR diversity influenced the population and 
evolutionary dynamics of the phage, as well as the evolutionary dynamics of the 
host.  
 
These analyses show that phage population sizes were larger and persisted longer 
in populations with lower CRISPR diversity, which is consistent with previous studies 
(van Houte et al., 2016b). Our results indicate that phage population size is 
increasingly limited by host diversity, because increasing host diversity reduces the 
proportion of susceptible individuals in the host population. This dilution effect of host 
resistance diversity is an important factor in explaining why genetically diverse host 
populations often have reduced pathogen loads (Keesing et al., 2006; Ostfeld & 
Keesing, 2012; Civitello et al., 2015). The finding that resistant hosts can protect the 
susceptible fraction of the population is also consistent with the epidemiological 
concept of “herd immunity” (Fine et al., 2011). While herd immunity has been 
extensively studied in eukaryotes, recent work has suggested it may be important in 
understanding bacteria-phage dynamics (Payne et al., 2018), a suggestion that our 
results provide further experimental support. This result also qualitatively matches 
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theoretical predictions of how host diversity should affect pathogen spread in a 
system with matching allele genetic architecture (Lively, 2010).  
 
In theory, this kind of ecological effect can in turn shape the evolutionary dynamics of 
the bacteria-phage interaction, since smaller phage population sizes will decrease 
the mutation supply and hence the evolutionary potential of the phage (Antia et al., 
2003; Dennehy et al., 2006; Yates et al., 2006). We did observe that the evolution of 
phage host range expansion peaked at intermediate levels of CRISPR diversity. This 
is likely because increasing CRISPR diversity dilutes susceptible hosts, which results 
in smaller phage population size and hence less genetic variation on which selection 
can act. Simultaneously, increasing host diversity can increase selection for escape 
mutations. These two effects in dynamic tension can maximise evolutionary 
emergence at intermediate host diversity (Chabas et al., 2018). The kind of 
interdependence between ecological and evolutionary dynamics of phage suggested 
by this study provides important context for other factors that can affect – and are 
affected by - evolutionary emergence. For example, the ability of a phage to escape 
a particular CRISPR spacer can influence host population structure by determining 
colony heterogeneity (Pyenson & Marraffini, 2020). Another example is when 
CRISPR immunity is incomplete, because phage with anti-CRISPR (Acr) genes can 
vary in the degree to which they inhibit the CRISPR immune response (Landsberger 
et al., 2018). Differences in the degree of CRISPR immunity because of Acr diversity 
have been shown to affect the evolutionary emergence of escape phage 
(Chevallereau et al., 2020). Understanding of how these factors interact with 
CRISPR allele diversity to affect the emergence and spread of escape phage will be 
important in future studies of CRISPR ecology and evolution. 
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In this study, we focussed on host populations where different CRISPR resistance 
genotypes were at equal starting frequencies, but natural communities are often 
composed of a few very common and many rare variants (Pachepsky et al., 2001; 
McGill et al., 2007). This likely matters for the observed dynamics, since the 
proportion of susceptible hosts has a large impact on the probability of evolutionary 
emergence of pathogens (Chabas et al., 2018). Also, we focussed our analysis on 
the simple case where a diverse host population is infected by a clonal pathogen 
population. In nature, pathogen populations will frequently be genetically diverse as 
well (Hudson et al., 2006; Telfer et al., 2010), and increased levels of pathogen 
diversity may affect the benefits of host diversity (Ganz & Ebert, 2010). Indeed, 
previous studies of CRISPR-phage interactions suggest that infection by two 
different phages can increase bacteria-phage coexistence compared to infections 
with a single phage (Paez-Espino et al., 2013; Paez-Espino et al., 2015). Further, 
infection by diverse phage can select against CRISPR immunity in favour of surface-
based resistance at the level of the host population, but also select for individual 
CRISPR clones with a more diverse array of spacers (Broniewski et al., 2020). The 
empirical system used in this study offers both a unique ability to link genotypes and 
phenotypes, tight experimental control over the infectivity matrix of the host-phage 
interaction, and a clear link with theoretical predictions. These features will make it 
an ideal system for more detailed studies to understand how the composition of the 
host population and the relative diversity levels of the phage and host shape 
coevolutionary interactions.  
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Materials & Methods 
 
Bacterial strains and phage 
 
Evolution experiments were carried out using wild-type Pseudomonas aeruginosa 
UCBPP-PA14 (which has two CRISPR loci, CRISPR1 and CRISPR2), UCBPP-PA14 
∆pilA (this strain lacks the pilus, which is the phage DMS3 receptor, and therefore 
displays surface-based instead of CRISPR-based resistance) and phage DMS3vir 
(Zegans et al., 2009). We used P. aeruginosa UCBPP-PA14 csy3::lacZ (Cady et al., 
2012), which carries an inactive CRISPR-Cas system, for phage amplification, and 
for top lawns in phage spot and plaque assays. P. aeruginosa PA14 csy3::lacZ, 
Escherichia coli DH5α (NEB), E. coli CC118 λpir (NEB), and E. coli MFDpir 




To control the levels of CRISPR diversity in our evolution experiments, we 
established a library of 24 P. aeruginosa PA14 clones each carrying a single spacer 
in CRISPR2 (bacteriophage-insensitive mutants; BIMs). We also independently 
evolved 24 phage mutants that could infect each one BIM (escape phage).  
 
We designed 5 treatments in which we manipulated the level of CRISPR spacer 
diversity, based on the BIM library: monocultures (1-clone), or polycultures 
consisting of 3, 6, 12 and 24 clones. In order to monitor the population dynamics and 
relative fitness of individual bacterial clones within the polyculture treatments over 
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the course of the experiment, we transformed 8 BIMs to carry a lacZ reporter gene. 
The LacZ gene encodes the β-galactosidase enzyme that hydrolyses X-gal, resulting 
in the production of a blue pigment. For each of the polyclonal treatments, a single 
BIM carrying the lacZ reporter gene was included. 8 BIMs were chosen for 
transformation so that a single clone could be monitored in each of the 3-clone 
mixtures (BIMs 1, 4, 7, 10, 13, 16, 19, and 22; see Table A3.1) 
 
From fresh overnight cultures of each BIM, we made mixes of equal proportion of 
each clone corresponding to the diversity treatments. To monitor the population 
dynamics and competitive performance of all bacterial clones with an active CRISPR 
system, we also added PA14 ∆pilA (which is fully resistant to phage DMS3vir via 
surface-based resistance and has a distinct “smooth” colony morphology) to each 
mix in equal proportion to the CRISPR-carrying fraction of the population. We then 
inoculated 6ml of M9 minimal media (supplemented with 0.2% glucose; M9m) with 
bacteria from the mixed overnight cultures at a dilution of 1:100. Approximately 
1x106 pfu ml-1 of the escape phage targeting the labelled BIM were then added to 
each vial. We also established 1- and 24-clone treatments with ancestral phage as 
controls. Polyclonal treatments consisted of 8 biological replicates (N=8) to ensure 
that both BIMs and phage were equally represented across treatments, while the 1-
clone treatments consisted of 24 biological replicates (N=24). Glass vials were 
incubated at 37˚C while shaking at 180rpm. At 1, 2, and 3 days-post infection (dpi), 
the sampling of the phage and bacterial culture was repeated as described below. 
Cultures were transferred 1:100 to fresh media after sampling had been carried out. 
The experiment was terminated at 3 dpi.  
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Sampling proceeded as follows. Each day 180μl of culture was taken from each vial 
and phage was extracted using chloroform. Phage titres were determined by serially 
diluting extracted phage in 1x M9 salts, and then spotting 5μl of each dilution on a 
top lawn of P. aeruginosa PA14 csy3::lacZ, which was then incubated at 37˚C for 
24hrs. Phage titres were calculated from this assay. The detection limit of phage 
spot assays is 102 pfu ml–1. To monitor bacterial densities, culture samples were 
serially diluted in 1x M9 salts, and then plated on LB agar + 40µg/ml X-gal + 0.1mM 
IPTG, and incubated for 48hrs at 37˚C. The density of SM, CRISPR and the labelled 
BIM was then calculated. SM were differentiated from CRISPR clones by their 
“smooth” colony morphology, and the labelled BIM was identified by the blue:white 
screen.  
 
We assessed the competitive performance of the all BIMs relative to the ∆pilA strain, 
and the labelled BIM relative to non-labelled BIMs by calculating selection rate (r) 
each day (t) from 1-3 (n) dpi (rn = (ln [density strain A at tn/density strain A at tn-1] – 
ln[density strain B at tn/density strain B at tn-1])/day) (Lenski, 1991; Travisano & 
Lenski, 1996), which expresses competitive performance as the natural log of the 
relative change in density of one competitor against another. We decided to 
calculate selection rate instead of relative fitness (W) as used in Westra et al. (2015), 
because W is very sensitive to starting densities and hence becomes increasingly 
skewed at later timepoints. Applied to our data, it consequently produced impossibly 






We examined phage evolution during the experiment by sampling 12 individual 
plaques from each replicate that had detectable levels of phage from 1 to 3 dpi, 
which were amplified on PA14 csy3::lacZ overnight in LB, at 37˚C and shaking at 
180rpm. Phage were extracted using chloroform, and then diluted 1000-fold. 
Samples of each phage were then applied on lawns of each of the 24 BIMs and 
PA14 csy3::lacZ. A successful infection was indicated by a clear lysis zone on the 
top lawn. Phage were classified according to whether they had expanded their 
infectivity range (could infect the original susceptible clone and a new clone in the 
BIM library). Of the phages that had undergone a host shift (lost infectivity to the 
original clone and could only infect a new clone), we confirmed their expanded 
infectivity range by sequencing the old and new protospacers on the evolved phage 
genome (SourceBioscience, UK). We also sequenced the relevant protospacers of 
the pre-evolved escape phage from the BIM-phage library and ancestral DMS3vir. 




All statistical analyses were carried out in R v3.5.3 (R Core Team, 2018). 
Generalised linear mixed models (GLMMs) were used throughout, and replicate was 
treated as a random effect in all models. Days post-infection (dpi) was treated as a 
continuous variable and CRISPR allele diversity as a categorical variable. Model 
selection followed a nested approach, where full versus reduced models were 
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compared using information criteria (Burnham & Anderson, 2003, 2004), as well as 
focussed comparisons of observed and predicted values. The overall statistical 
significance of the single and interaction effects of fixed effects (that is, treatment 
and dpi) was assessed using ANOVA, which gives an F- and associated p-value. 
Simple Bayesian GLMMs from the MCMCglmm (Hadfield, 2010) package were used 
to analyse phage evolution to overcome model conversion issues encountered with 
this dataset. These models used a probit transformation (the inverse standard 
normal distribution of the probability) and a flat prior. The overall statistical 
significance of the single and additive effects of fixed effects in these models was 
assessed using Likelihood Ratio (LR) tests and their associated p-values using the 
VCVglmm package (Brown, 2019). Where possible, exact p-values are given, but R 
is unable to give exact values when p < 2.2 x 10-16. When phage titre was 
considered as the response variable, data was log-transformed to improve model fit 
after adding 1 to every value. Credibility intervals around model coefficients and 
predictions were calculated to the 95%, 89% and 67% level to give the reader a 
clearer indication of effect size. All R code used for analyses and figures is available 
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Chapter 4: CRISPR-Cas immunity leads to a coevolutionary 
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in publication. They have been formatted according to submission requirements and 
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CRISPR-Cas is an adaptive prokaryotic immune system that prevents phage 
infection. By incorporating phage-derived “spacer” sequences into CRISPR loci on 
the host genome, future infections from the same phage genotype can be 
recognised and the phage genome cleaved. However, phage can escape CRISPR 
degradation by mutating the sequence targeted by the spacer, allowing them to re-
infect previously CRISPR-immune hosts, and theoretically leading to coevolution. 
Previous studies have shown that phage can persist over long periods in populations 
of Streptococcus thermophilus that can acquire CRISPR-Cas immunity, but it has 
remained less clear whether this coexistence was due to coevolution, and if so, what 
type of coevolutionary dynamics were involved. In this study, we performed highly 
replicated serial transfer experiments over 30 days with S. thermophilus and a lytic 
phage. Using a combination of phenotypic and genotypic data, we show that 
CRISPR-mediated resistance and phage infectivity coevolved over time following an 
arms race dynamic, and that asymmetry between phage infectivity and host 
resistance within this system eventually causes phage extinction. This work provides 
further insight in the way CRISPR-Cas systems shape the population and 




Clustered Regularly Interspaced Short Palindromic Repeats and their associated cas 
genes (CRISPR-Cas) form an adaptive immune system that is found in 
approximately 50% of all bacteria and 90% of archaea (Grissa et al., 2007a). 
CRISPR-Cas confers immunity to phage infection by incorporating phage-derived 
sequences into CRISPR loci on the host genome. These loci consist of repeating 
sequences (“repeats”) that are interspaced by sequences (“spacers”) derived from 
phage and other mobile genetic elements of typically around 30nt in length. RNA 
transcripts of CRISPR loci are processed and form a ribonucleoprotein complex with 
Cas proteins that can recognise and cleave complementary nucleic acid sequences, 
preventing future infections by the same phage genotype. CRISPR-Cas systems are 
highly diverse, and are currently ordered into two classes, six types and 33 subtypes 
based on their cas gene composition, gene synteny and CRISPR repeat sequences, 
with clear differences in the molecular mechanisms of different variants (Koonin et 
al., 2017). 
 
In some natural environments, bacteria with CRISPR-Cas systems appear to 
coevolve with phage over long time periods (Andersson & Banfield, 2008; Laanto et 
al., 2017). However, studying the dynamics of these coevolutionary interactions 
under controlled laboratory conditions has been limited by the availability of 
adequate model systems. Specifically, while many bacteria encode CRISPR-Cas 
immune systems, under laboratory conditions the vast majority do not evolve 
CRISPR-based immunity upon phage or plasmid infection, or do so at such low 
frequencies that they are detectable only with deep-sequencing approaches. Such 
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low-frequency CRISPR evolution is unlikely to significantly contribute to the 
reciprocal selection between the bacteria and the phage. Currently, only two 
bacterial species have been found to naturally evolve (almost) exclusively CRISPR-
based immunity under laboratory conditions: Streptococcus thermophilus strains 
DGCC7710 and LMD-9 (Deveau et al., 2008; Horvath et al., 2008; Horvath et al., 
2009), and Pseudomonas aeruginosa strain UCBPP-PA14 (Westra et al., 2015).  
 
Early studies with S. thermophilus demonstrated that phage can overcome CRISPR 
immunity by evolving point mutations in the sequence targeted by the spacer (the 
“protospacer”), or in the protospacer-adjacent motif (PAM) (Deveau et al., 2008), a 
conserved sequence immediately adjacent to the protospacer that is used by the 
bacteria to discriminate between self (i.e. CRISPR loci) and non-self (i.e. phage) 
DNA (Mojica et al., 2009; Semenova et al., 2011; Westra et al., 2013). This 
observation suggested a possible scenario for coevolution in free-running systems, 
where bacteria acquire spacers over time and phage escape via point mutations in 
the corresponding protospacers or PAMs (Childs et al., 2012; Weinberger et al., 
2012; Iranzo et al., 2013). Consistent with this idea, it was reported that S. 
thermophilus can coexist with phage over many generations, and that for each 
treatment the single experimental population displayed large fluctuations in its 
spacer repertoire and an increase in the frequency of point mutations in phage 
genomes over time (Paez-Espino et al., 2013; Paez-Espino et al., 2015; Sun et al., 
2016). However, a more recent study suggested that coevolution is unable to explain 
long-term coexistence of S. thermophilus and its phage, suggesting instead that this 
may be driven by back mutation of bacteria with CRISPR immunity to sensitive 
phenotypes (Weissman et al., 2018a), which would provide a continuous supply of 
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sensitive hosts for phage to amplify in. Such loss of CRISPR immunity due to 
mutation has also been observed at high frequencies in Staphylococcus epidermidis 
(W. Jiang et al., 2013), and reversion to sensitive phenotypes more generally may be 
an important mechanism for bacteria-phage coexistence (Chaudhry et al., 2018).  
 
Given the lack of clarity surrounding the role, if any, and the type of CRISPR-phage 
coevolution for bacteria-phage coexistence, we performed highly replicated, long-
term (30-day) serial transfer experiments with S. thermophilus and its lytic phage 
2972. Our phenotypic assays demonstrate that bacteria and phage coevolved in 
these experiments during at least the first 9 days (approximately 70 generations). 
We next examined the type of coevolutionary dynamics during this period, with a 
clear distinction between fluctuating selection dynamics (FSD), where rare host and 
pathogen genotypes are favoured through negative frequency-dependent selection, 
and arms race dynamics (ARD), where host resistance and phage infectivity 
increase over time (Vale & Little, 2010). We found that CRISPR-mediated immunity 
and phage infectivity increase over time. Further, our genotypic data show that 
patterns of resistance and infectivity were explained by bacteria acquiring novel 
spacers against the phage, and the phage evolving mutations in the regions targeted 
by the spacers. Collectively, the data show that coevolution is likely an important 
factor in the coexistence of bacteria and phage in this empirical system, and that this 




Strains used in the study 
 
We used the lactic acid bacterium Streptococcus thermophilus DGCC7710 wild-type 
(WT) and its lytic pac-type phage 2972 (GenBank: NC_007019.1) (Lévesque et al., 
2005) as a model system. DGCC7710 has four CRISPR-Cas systems, two of which 
(CRISPR1 and CRISPR3) are active during infection with phage 2972 and both are 
classified as Type II-A (Horvath et al., 2008; Carte et al., 2014). CRISPR1 has 32 
spacers and CRISPR3 has 12 spacers (Grissa et al., 2007b; Horvath et al., 2008), 
none of which are perfectly complementary to a PAM-flanked sequence in the phage 
2972 genome. 
 
Phage 2972 amplification 
 
An overnight culture of S. thermophilus was transferred 1:10 into fresh LM17 
medium (M17 broth supplemented with 0.5% α-Lactose) containing 10mM CaCl2 and 
incubated shaking at 180 revolutions per minute (rpm) at 42˚C. When the culture 
reached log phase (OD600 ~ 0.25) approximately 106 plaque forming units (pfu) of 
phage 2972 were added and the culture was incubated under the same conditions 
for two hours, at which point cells had fully lysed. Lysates were centrifuged and 
filtered through a 0.22 µm filter, and the resulting phage stocks were stored at 4˚C. 
 
Long-term co-culture experiment 
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Prior to commencing the experiment, S. thermophilus was acclimatised in LM17 
medium at 42˚C and 180 rpm for 2 days, with a 1:100 transfer into fresh LM17 after 
24 hours (approximately 106 cfu). To start the co-culture experiment, overnight 
cultures of the bacteria were transferred 1:100 into 6ml LM17 media supplemented 
with 10mM CaCl2 in glass vials. They were then infected with either 109, 108, 107 or 
106 pfu of phage 2972, with 12 independent replicate experiments per treatment, 
followed by incubation at 42˚C while shaking at 180 rpm. Replicates were transferred 
1:100 into fresh LM17 + 10mM CaCl2 every 24 hours and phage titres and bacterial 
densities were measured every 24 hours for a period of 30 days, or until no phage 
was detected for four consecutive days. Bacterial densities were determined through 
plating and colony counts, while phage densities were measured by plaque assays. 
These were performed by mixing phage dilutions with WT bacteria in soft agar 
overlays (LM17 + 10mM CaCl2 and 0.5% agar), poured onto hard agar (LM17 + 




Phage survival and mean time to extinction over the course of the experiment were 
analysed using a Cox proportional hazards model from the survival package 
(Therneau & Lumley, 2015). 
 
Measuring the evolution of infectivity and resistance  
 
To measure whether host resistance and phage infectivity evolved during their co-
culture, we isolated phage clones and bacterial clones from the treatment where 
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bacteria were infected with 108 pfu phage. To give sufficient power in this analysis, 
we focussed on eight replicate experiments from this treatment where phage 
persisted for at least nine days, a period which we estimated to be sufficiently long 
for significant coevolution to take place. Phage extracted from 1, 4 and 9 days post-
infection (dpi) were subjected to plaque assays as described above. Three time 
points were chosen as a minimal requirement for the downstream time shift analysis 
to monitor whether coevolution took place and to determine the coevolutionary 
dynamics (see below). For each replicate and time point, twelve plaques were 
randomly picked and amplified in 96 well plates containing LM17 + 10mM CaCl2 in 
which WT bacteria were inoculated 1:100 from a fresh overnight culture. Bacteria 
extracted from the same time points were diluted and plated overnight, and twelve 
colonies from each replicate were picked at random and used to make soft agar 
overlays on LM17 agar lawns. To examine the evolution of phage infectivity for each 
of the eight replicates, the 36 phage clones that were isolated (12 phage clones x 3 
time points) were stamped using a 96-pin replicator onto 36 bacterial lawns 
corresponding to the bacterial clones isolated from the same replicate (i.e. 12 
bacterial clones x 3 time points). Phage were classified as being infective against a 
particular bacterial clone if a clear lysis zone was visible on the lawn after incubation 
at 42˚C for 24 hours. If no lysis zone was visible, the host was classified as resistant.  
 
Evolution of infectivity and resistance 
 
Using the data from the experiments described above, we measured the evolution of 
phage infectivity as the proportion of bacterial clones that phage from each time 
point from the same replicate experiment could infect (i.e. how phage infectivity 
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range changed over time). In a similar way, we measured the evolution of host 
resistance as the proportion of all phage genotypes from the same replicate 
experiment that could be resisted by bacteria from each time point (i.e. how host 
resistance range changed over time). Infectivity or resistance was analysed in a 
Generalised Linear Model (GLM) with genotype as a fixed effect and a binomial 
family with a logit link function. Mean infectivity or resistance was then analysed for 
each time point in a Generalised Linear Mixed Model (GLMM) using the lme4 
package (Bates, 2015), with time point as a fixed effect and replicate as a random 
effect. Model coefficients and confidence intervals were transformed from logits to 




Because the susceptibility and resistance of bacterial clones to phage from past, 
present or future time points was determined (Table 4.1), our phenotypic assay also 
served as a time-shift experiment (Gaba & Ebert, 2009). Time-shift experiments 
involve challenging samples of host or pathogen populations from a particular time 
point against samples of pathogen or host populations from contemporary, past and 
future host or pathogen populations. Time-shift experiments are a powerful tool to 
characterise underlying coevolutionary processes, and have been used in several 
host-pathogen systems (Koskella & Lively, 2007; Gandon et al., 2008), including 
bacteria-phage (Buckling & Rainey, 2002a; Hall et al., 2011b; Koskella, 2014). Our 
phage infectivity and host resistance data was analysed as a time-shift experiment 
by first scoring each pairwise challenge as ‘past’, ‘present’, or ‘future’, with reference 
to the phage’s background compared to the host. Infectivity was then analysed in a 
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GLMM with phage background as a fixed effect and replicate, host timepoint, and 
phage timepoint as random effects. Models had a binomial family with a logit link 
function. 
 
To test for the relative importance of arms race dynamics (ARD) versus fluctuating 
selection dynamics (FSD), we estimated the strength of the Genotype x Environment 
(GxE) effect on infectivity and resistance following Hall et al. (2011b). Under a simple 
arms race, all hosts should be more susceptible to phage from their future compared 
to their past or present, independent of genotype. Environment (E) therefore refers to 
the time point from which phage originate in pairwise challenges. By contrast, under 
fluctuating selection different host genotypes will vary in their susceptibility to hosts 
from their past, present or future. Measuring which proportion of the variation in 
susceptibility across phage environments can be explained by the interaction 
between the environment and host genotype (G) can therefore be used to measure 
the relative contribution of FSD. Increasing values of this proportion (GxE / E) relate 
to increasing differences in susceptibility among host genotypes. We estimated this 
by calculating the ratio of the mean square (MS) of an Environment-only model to 
the MS of a GxE model for each replicate at each time point. These ratios were then 
analysed in a GLMM with time point as a fixed effect and replicate as a random 




For all experiments, statistical analyses were carried out in R v3.5.0 (R Core Team, 
2018), and graphics were generated using r-base and the ggplot2 package 
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(Wickham, 2009). Model selection followed a nested design, and the final models in 
all analyses were selected based on the reduction of heteroskedacity, χ2 tests, and 
AIC comparisons (Akaike, 1973; Burnham & Anderson, 2003, 2004). Where 
appropriate, tests were Bonferroni adjusted using the multicomp package (Hothorn 
et al., 2008).  
 
Spacer sequence analysis 
 
For all bacterial clones that were isolated from the eight replicate experiments where 
bacteria had been infected with 108 pfu of 2972, expansion of the CRISPR1 and 
CRISPR3 arrays was analysed using colony PCR to determine whether spacer 
acquisition had taken place (12 clones x 3 time points x 8 replicates = 288 clones in 
total). The following primers were used: CRISPR1 5’-tgctgagacaacctagtctctc-3’ and 
5’-taaacagagcctccctatcc-3’; CRISPR3 5’-ctgagattaatagtgcgattacg-3’ and 5’-
gctggatattcgtataacatgtc-3’. Clones that had acquired new spacers were further 
analysed by Sanger sequencing of the amplicon (Source Bioscience, UK), followed 
by mapping of the spacers against the phage 2972 genome (Accession: NC 
007019.1) using BLAST followed by manual verification with Geneious v9.1.8 
(Kearse et al., 2012). Spacer diversity was calculated as the pairwise difference 
(PWD) among nucleotides between spacer sequences. The effect of spacer number 
and diversity on infectivity was analysed in a GLMM, with either number or diversity 
as fixed effects and replicate as a random effect. Models had a binomial family and 
logit link function.  
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Phage sequence analysis 
 
To understand whether phages could escape CRISPR immunity through target site 
(protospacer) mutation, we selected phage clones (out of the 288 total phage clones 
isolated, see above) and sequenced the protospacer(s) that would match the 
spacer(s) present among the 12 isolated bacterial clones in a replicate. We then 
analysed the protospacers and their associated protospacer-adjacent motifs (PAMs) 
for SNPs that could explain the ability of the phage to overcome CRISPR immunity. 
For phage clone selection we used the individual infectivity matrices generated from 
our phenotypic assays (Table A4.1), and we only sequenced phage clones from 
infection matrices that showed phage infectivity on hosts that had acquired spacers 
i.e. excluded from analysis were phages from those matrices where none of the 12 
host clones of a replicate had acquired spacers or where none of the 12 phage 
clones of a replicate showed infectivity. Sequenced phage clones were taken from 1, 
4 and 9 dpi. At least two individual phage clones were selected from each matrix that 
was analysed, based on their ability to infect CRISPR-immune hosts. When an 
infection matrix showed a high degree of variation between phage clones, more than 
two phage clones were analysed so that most of the variation in infectivity would be 
covered (e.g. in the matrix of replicate 7, T9 phage:T9 host, phage clones 1, 2, 5, 6 , 
8, and 9 were selected [Table A4.1]). Where possible, one phage clone that did not 
show infectivity to any of the 12 bacterial clones from each matrix was taken along to 
serve as a control for protospacer sequencing, alongside an ancestral phage as 
control. Primers for protospacer sequencing were designed in Geneious by using the 
available spacer information (Tables A4.2 & A4.3). PCR amplicons of total of 51 
phage clones were generated by performing PCR on the filtered phage stock, which 
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was followed by Sanger sequencing. To identify point mutations, sequences were 
first mapped to the 2972 genome using Geneious. Single nucleotide polymorphisms 
(SNPs) in either the seed sequence or PAM were identified (Deveau et al., 2008; 
Horvath et al., 2008), and SNP locations were then compared against the 
protospacer sequence targeted by the CRISPR array of each clone that phage had 
been challenged against (Table A4.4). Phage with SNP(s) in the seed sequence or 
PAM of the targeted protospacers were scored as ‘predicted infective’. We found that 
approximately 70% (241/348) of predicted infectious phage were measured as 
successfully infecting a host (Table 4.3). The remaining predicted infections that 
were not measured as successful may be attributable to partial CRISPR resistance 
or other resistance mechanisms such as surface modification. We also expect some 
degree of experimental error in our assay given that detection of lysis zones is a 
relatively crude method of discerning infectivity/resistance. Using data from the 
phenotypic assay, we then analysed the effect of mutation on infectivity. The effect of 
escape by point mutation on infectivity was modelled in a GLMM as the proportion of 
infections associated with phage that had a SNP in the protospacer seed sequence 
or PAM. We analysed the effect of the evolution of the number of SNPs in all 
targeted sequences matching the host’s CRISPR array by first subtracting the 
number of targeted protospacers that had evolved from the total number of spacers 
in each host. This gives the number of targeted sequences that had not evolved. The 
proportion of infections was then modelled against these values. All models included 




We set out to first examine the generality of the previously reported population 
dynamics following infection of S. thermophilus DGCC7710 with a single phage 
2972. We therefore infected 12 replicate experimental populations of S. thermophilus 
DGCC7710 with either 106, 107, 108 or 109 plaque forming units (pfu) of phage 2972 
(12 independent replicates per treatment; 48 populations in total), and monitored the 
bacterial and phage population densities on a daily basis for 30 days. For the first 
three days following infection, phage titres remained fairly constant in most replicates 
between 106 -108 pfu ml-1, with the exception of the highest phage treatment (109 pfu) 
where phage and bacteria went extinct in 11 out of 12 replicates (Fig. 4.1). Lower 
phage titres were correlated with higher host densities (z = -0.31, 95% CI = -0.42, -
0.19, p < 0.0001). With the exception of the 109 treatment, this relationship between 
phage and host titres was the same among treatments (F2,551 = 2.24, p = 0.11). At 16 
days post-infection (dpi), the phage had gone extinct in 44 / 48 replicates, and phage 
persisted for the entire 30-day duration of the experiment in two replicates, one each 
in the 107 and 108 pfu treatments. For the treatments where bacteria survived, the 
mean time until phage extinction in days was as follows: for the 109 pfu treatment: 2 
± 0.54 days; 108 treatment: 11.50 ± 1.77 days; 107 treatment: 11.50 ± 2.12 days; and 
106 treatment: 7.67 ± 1.67 days (mean ± standard error). 
 
Using these experimental lines, we first determined whether the coexisting bacteria 
and phage had evolved during their co-culture. Since the population dynamics 
associated with the 106-108 pfu infection regimes was virtually identical, we decided 




Figure 4.1 Phage and host population dynamics over time in each replicate 
A-D) 109-106 pfu phage treatments, respectively, with replicate identity indicated 
above each sub-panel. Phage titres (plaque-forming units; pfu ml-1) are shown in black 
and host densities (colony-forming units; cfu ml-1) are shown in blue. The level of 
detection is 200 pfu ml-1 (dashed line).  
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sufficient power in our analyses and deduce coevolutionary dynamics, we selected 
replicates where bacteria and phage coexisted for at least nine days, resulting in a 
total of eight replicate populations that were examined in detail (Fig. 4.1). We then 
isolated 12 bacterial clones and 12 phage clones from each replicate at 1, 4 and 9 
days post-infection (dpi). Using the 288 phage and 288 bacterial isolates, we first 
examined whether the phage and bacteria had evolved increased infectivity and 
resistance over time. This was done by measuring the resistance of each individual 
bacterial clone against all phage clones derived from the same replicate, and 
measuring the infectivity of each individual phage clone against all bacterial clones 
from the same replicate. This analysis revealed that mean phage infectivity (the 
proportion of all host genotypes that can be infected by a given phage genotype) 
increased significantly from 0.29 (CI = 0.08, 0.48) at 1 dpi to 0.57 (CI = 0.37, 0.74) at 
4 dpi, but remained stable at 0.53 (CI = 0.33, 0.74) from 4 to 9 dpi. Mean host 
resistance (the proportion of all phage genotypes resisted by a given host genotype) 
increased significantly each time point, from 0.01 (CI = 0.00, 0.05) at 1 dpi to 0.67 
(CI = 0.18, 0.96) at 4 dpi, and to 0.99 (CI = 0.96, 0.99) at 9 dpi (Fig. 4.2). 
Collectively, these data show that bacteria evolved to resist essentially all phage 
genotypes by 9 dpi, but phage did not evolve high levels of infectivity to match. 
 
Having established that bacteria evolved increasing resistance and that phage 
evolved increasing infectivity over time, we next examined whether both species 
coevolved; and if so, what type of coevolutionary dynamics were associated with this 
system. To answer this question we performed a phenotypic time-shift experiment 
whereby bacteria were exposed to phage from their past, present and future (Gaba 




Figure 4.2 Evolution of infectivity and resistance over time 
A) Phage infectivity over time, represented as the proportion of host genotypes from 
all time points that were infected by a given phage genotype in each replicate. B) 
Host resistance over time, represented as the proportion of phage genotypes from all 
time points that were resisted by a host genotype in each replicate. Means and 95% 
CIs are shown (N = 8). 
 Phage 





1 Present Future Future 
4 Past Present Future 
9 Past Past Present 
 
Table 4.1 Pairwise challenges between phage and hosts in the time shift assay 
Numbers indicate the time points (days post-infection) analysed. Past, present or 
future refer to if hosts were contemporaneous or not with respect to the phage. 
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resistance patterns over time. Because individual genotypes may differ in their 
response to time-shift challenges, generalized linear mixed models (GLMMs) with 
replicate, host timepoint, and phage timepoint as random effects and phage 
background (Tab. 4.1) as a fixed effect were used to analyse time-shift data. This 
analysis showed that the original time-point of the phage with respect to the host had 
a significant effect on infectivity (2(4,10044) = 5.35, p < 0.0001, R2 = 0.88). Hosts were 
least susceptible to infection from past phage, more susceptible to contemporaneous 
phage, and most susceptible to phage from their future (Fig. 4.3A). This pattern of 
increasing susceptibility from past to future phage generally held true when each 
pairwise combination of host and phage time point was considered (Figure A4.1 & 
Tab. 4.2). Finally, host susceptibility to phage from the same time point declined 
consistently from 1 to 9 dpi (Fig. 4.3B). These data are consistent with an arms race 
dynamic (ARD) where hosts and pathogens escalate resistance or infectivity over 
time, but one in which host resistance eventually outpaces pathogen infectivity.  
 
We formally tested for the relative importance of arms race versus fluctuating 
selection in our experiment by estimating the strength of the genotype X environment 
(GxE) effect on infectivity and resistance (Hall et al., 2011b). Stronger GxE effects 
are consistent with stronger fluctuating selection (see Experimental Methods). This 
analysis showed that variation among genotypes was weak, consistent with a limited 
GxE effect (Figure A4.2A & B). The strength of the GxE effect did not change 
significantly with respect to time point for either phage infectivity (2(2,24) = 1.93, p = 
0.38, R2 = 0.13) or host resistance (2(2,24) = 1.46, p = 0.48, R2 = 0.11). Collectively, 
these data demonstrate that S. thermophilus DGCC7710 and phage 2972 coevolved 
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Figure 4.3 Results from time-shift experiment 
A) Proportion of hosts infected when phage were from the host’s past, present or 
future. B) Proportion of hosts infected by phage from the same time point (days post-
infection). The dotted line is for illustrative purposes. Means are shown. 95% CIs 










Infectivity 95% CI 
1 1 0.98 0.80---1.00 
4 1 0.17 0.01---0.20 
9 1 0 0.00—0.00 
1 4 0.90 0.80---1.00 
4 4 0.74 0.67---0.97 
9 4 0.01 0.00---0.19 
1 9 0.85 0.80---0.99 
4 9 0.79 0.78---0.98 
9 9 0.36 0.07---0.56 
 
Table 4.2 Mean proportion and 95% confidence interval (CI) of hosts infected and 
phage resisted in pairwise challenges in the time-shift experiment, broken down by  
the day from which the host or phage originated. Values are rounded to two decimal 
places. 
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under these experimental conditions, and that the dynamics of their coevolution 
predominantly follows an arms race.  
 
Based on previous studies showing that S. thermophilus typically acquires spacers in 
response to phage exposure (Deveau et al., 2008; Paez-Espino et al., 2013; Paez-
Espino et al., 2015), we predicted that this ARD was driven by reciprocal adaptation 
of the hosts’ CRISPR array and the phage protospacers it targets. To test this, we 
first performed PCR analysis on the CRISPR1 and CRISPR3 loci of each bacterial 
clone to verify that the mechanistic basis of resistance was in fact due to the 
acquisition of novel CRISPR spacers. This revealed that the mean number of 
spacers per clone increased over time (2(6,1140) = 32.9, p < 0.0001) (Fig. 4.4A), and 
that all clones sequenced at 9 dpi had acquired at least one spacer (M = 0.55, CI = 
0.45, 0.65) (Fig. 4.4B). Comparison of these spacer sequences with the 2972 
genome confirmed that they were acquired from the phage.  
 
Using these sequencing data we determined the level of spacer diversity that 
naturally evolved within each replicate, since this is an important determinant of 
CRISPR-phage coevolution (Childs et al., 2014; van Houte et al., 2016b). Consistent 
with deep sequencing analyses of previous co-culture experiments (Paez-Espino et 
al., 2013; Paez-Espino et al., 2015), our data showed that spacer diversity, 
measured as the pairwise difference (PWD, with 0 indicating all spacers were shared 
among clones, and 1 indicating all spacers were unique) among spacer sequences, 
was generally low (grand mean = 0.25). Despite this, there was clear qualitative 
variation in spacer diversity between different replicates (Fig. 4.4C). Mean CRISPR 




Figure 4.4 Spacers acquired during coexistence of S. thermophilus and phage 
2972 
A) Number of acquired spacers per clone at each day post-infection (dpi). Means 
and 95% CIs are shown (N = 8). B) Mean relative frequency of clones with different 
numbers of acquired spacers at each dpi. No clone with >3 spacers was detected. 
Means and 95% CIs are shown (N = 8). C) Spacer diversity in each replicate, 
measured as the pairwise differences among spacer sequences in each replicate (x-
axis) at each time point (colours). 
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 low, but increasing, across the sampled time points (1 dpi = 1, 4 dpi = 1.5, 9 dpi = 
2.25). The diversity patterns become especially apparent when the spacers are 
mapped against the phage genome (Fig. 4.5) which shows that the spacer 
composition between time points can change completely, suggestive of selective 
sweeps of the population.  
 
Consistent with previous theory and data (Childs et al., 2014; van Houte et al., 
2016b) we found that host resistance increased with both the number of acquired 
spacers (C = 1.91, z = 17.22, p < 0.0001, R2 = 0.66) (Figure A4.3A) and sequence 
diversity in terms of PWD (C = 5.26, z = 0.27, p < 0.0001, R2 = 0.44) (Figure A4.3B). 
These data demonstrate that all clones that had acquired resistance had also 
acquired at least one novel spacer in either CRISPR1 or CRISPR3, suggesting that 
resistance is CRISPR-mediated. Further, Sanger sequencing of all CRISPR 
amplicons confirmed that all spacers that had been acquired indeed targeted the 
phage 2972 genome (Table A4.2). Spacers most frequently mapped to phage genes 
encoding hypothetical proteins compared to proteins with known functions, and the 
targeted genes tended to be at the distal end of the phage genome (Table A4.2). We 
next tested the hypothesis that the coevolutionary arms race we observed in these 
experiments was caused by reciprocal adaptation of the phage through the 
acquisition of point mutations in the target sequences. Such mutations have been 
observed in a previous co-culture experiment (Paez-Espino et al., 2015), and provide 
a known mechanism for phage to overcome CRISPR resistance (Deveau et al., 
2008). To examine whether phage infectivity could be explained by the acquisition of 
point mutations, we first selected from the phenotypic assays a representative 
number of 56 different phage clones with different infectivity patterns 
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Figure 4.5 Locations of newly-acquired spacers on the phage 2972 genome 
Histogram showing the location of acquired spacers in each replicate when mapped 
against the phage 2972 genome. Each dot represents a clone that had a spacer 
mapped to that region. Red, green and blue indicate 1, 4, and 9 days post-infection, 
respectively. Darker colours are the result of visual overlap between dots. Replicate 
identity is indicated above each sub-panel. 
  Predicted 
  - + 
Measured - 242 107 
+ 106 241 
 
Table 4.3 Contingency table of pairwise infections that were predicted to lead 
to phage escape based on protospacer sequence data 
Single nucleotide polymorphisms (SNPs) in either the seed sequence or PAM were 
identified, and SNP locations were then compared against the protospacer sequence 
targeted by the CRISPR array of each clone that phage had been challenged 
against. These were then compared against the pairwise infections measured in the 
phenotypic assay. “+” indicates a successful infection, “-“ indicates no infection.  
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 (i.e. covering both infective and non-infective phenotypes) across the three time 
points included in the phenotypic assay. We then PCR amplified their protospacer 
sequences based on the CRISPR spacer sequence data, followed by Sanger 
sequencing of the amplicons. This showed that 38 out of 51 selected phage clones 
had acquired at least one single nucleotide polymorphism (SNP) in the protospacer 
sequence or PAM (Fig. 4.6A); the majority (33) of which were protospacer mutations 
(Fig. 4.6B). Further, the majority (~70%) of phage that were predicted to be 
infectious based on sequence data were able to successfully infect hosts (Tab. 4.3), 
indicating that SNPs in the protospacer or PAM were generally sufficient to confer 
infectivity. The proportion of sequenced phage clones without SNPs in the 
protospacer or PAM from 4 dpi (10/22) was higher than phage clones from 9 dpi 
(4/26) (Table A4.3), which is consistent with the idea that CRISPR drives mutation of 
phage genomes in this empirical system (Paez-Espino et al., 2015). Crucially, 
analysis of the infectivity patterns of sequenced phage showed that the mean 
number of infected hosts was significantly higher when phage had a SNP in the 
protospacer sequence or PAM compared to phage with no detectable mutations 
(2(1,696) = 32.22, p < 0.0001, R2 = 0.31) (Fig. 4.6C). Finally, phage that had evolved 
SNPs in all sequences that were targeted by the host’s CRISPR array (0 targeted 
sequences) had significantly higher infectivity compared to phage that carried one or 
more unmutated target sequences (2(1,696) = 59.29 p < 0.0001, R2 = 0.74) (Fig. 
4.6D). These data demonstrate that the acquisition of point mutations in the 
protospacer sequence in response to evolution of CRISPR immunity is the primary 
mechanism of phage reciprocal adaptation, driving the increase in phage infectivity 




Figure 4.6 Protospacer sequence analysis and infectivity patterns 
A) Histogram showing the number of sequenced phage (out of 56) that did not have 
a detectable mutation, had a ‘random’ mutation outside of the protospacer, or had a 
‘protospacer-associated’ mutation either in the protospacer-adjacent motif (PAM) or 
the seed sequence. B) Number of sequenced phage with protospacer-associated 
mutations (out of 40) that had a single nucleotide polymorphism (SNP) in either the 
PAM or seed sequence. C) Mean proportion of hosts infected by phage that did or 
did not have a protospacer-associated SNP. The effect of random mutations is not 
included due to limited sample size. D) Mean proportion of hosts infected by phage 
that had a full or partial match to the host’s CRISPR array in terms of the number of 
targeted protospacer sequences that had not evolved by point mutation. Means and 




S. thermophilus DGCC7710 readily evolves CRISPR-based resistance in response 
to phage 2972 through spacer acquisition in two active CRISPR loci (CRISPR1 and 
CRISPR3). In return, phage can escape CRISPR immunity by evolving point 
mutations in the protospacer sequences targeted by CRISPR. This mechanism of 
host resistance and pathogen infectivity suggests a possible scenario for 
coevolution, where bacteria acquire spacers over time and phage accumulate 
escape mutations. 
 
Consistent with earlier work on S. thermophilus and phage 2972 (Paez-Espino et al., 
2013; Paez-Espino et al., 2015; Sun et al., 2016; Weissman et al., 2018a), we found 
that, with the exception of the highest initial phage concentration treatment, phage 
can coexist with bacteria over many generations despite the presence of CRISPR-
based host immunity. Furthermore, our phenotypic data using bacteria and phages 
isolated during the first 9 dpi demonstrated that they coevolved following an arms 
race dynamic (ARD), with hosts and phage evolving increased resistance and 
infectivity over time, and hosts being more resistant to phage from the past 
compared to present and future time points. To the best of our knowledge, evolution 
of phage resistance is exclusively driven by CRISPR-Cas in this empirical system 
(i.e. surface modification has not been reported in S. thermophilus DGCC7710 in 
response to phage infections, and we have also never observed it in our 
experiments). Consistent with this, we found that the underlying mechanism of 
coexistence during this time span appears to be predominantly reciprocal adaptation 
of the hosts’ CRISPR array and the phage protospacers it targets. Analysis of hosts’ 
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CRISPR arrays show that they readily acquire phage-derived spacers, that hosts 
acquire more spacers over time, and that host resistance is strongly associated with 
both spacer acquisition and spacer number. In turn, phage evolved via point 
mutations in the targeted protospacers. Correlating this with our phenotypic data 
shows that such escape phage were on average more infective. Further, we find that 
phage had evolved SNPs in all target sequences matching the host’s CRISPR array 
were most infective compared to those with an incomplete match.  
 
It is notable that while hosts evolve resistance against essentially all phage, this is 
not matched by similarly broad phage infectivity range; phage at the last time point (9 
dpi) could infect just over half of all hosts. The infectivity of contemporary phage also 
declines with time, suggesting that the evolution of host resistance “outpaces” that of 
phage infectivity.  This asymmetry between host resistance and phage infectivity is 
consistent with the idea that bacterial hosts are ‘ahead’ in coevolutionary arms races 
(Buckling & Brockhurst, 2012). While asymmetrical arms races in other studied 
bacteria-phage systems are generally driven by a binary shift to a phage-resistant 
surface mutant (Lenski & Levin, 1985; Westra et al., 2015), CRISPR-phage 
interactions suggest an alternative. Hosts can acquire multiple novel spacers with 
only a marginal cost (Vale et al., 2015), but phage mutation is limited by mutation 
supply (Lenski & Levin, 1985; Levin et al., 2013; Chabas et al., 2018; Chabas et al., 
2019). In addition, full phage infectivity requires mutations in all the protospacers 
targeted by the host CRISPR array, which becomes increasingly difficult when 
individual hosts and populations acquire a greater number and diversity of spacer 
sequences over time (Levin et al., 2013; van Houte et al., 2016b). It is likely that this 
asymmetry leads to the repeatable phage extinctions we observed.  
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Interestingly, this and previous studies occasionally found quasi-stable long-term 
coexistence of bacteria and phage (Paez-Espino et al., 2013; Paez-Espino et al., 
2015; Sun et al., 2016; Weissman et al., 2018a). Previous work suggests that this 
may be driven by back-mutation of resistant hosts towards sensitivity (Weissman et 
al., 2018a). These two mechanisms for bacteria-phage coexistence may operate in 
parallel, and their relative importance remains to be investigated. The relative 
importance of coevolution for phage persistence contrasts with what is observed for 
P. aeruginosa and its phage DMS3vir, where phage are unable to coevolve with the 
host due to the high levels of spacer diversity that naturally evolve (van Houte et al., 
2016b). In this system a continuous supply of sensitive hosts can allow for bacteria-
phage coexistence (Chabas et al., 2016; van Houte et al., 2016b; Westra et al., 
2017). 
 
Our data clearly shows that host genotype diversity richness (i.e. the number of 
hosts with different CRISPR arrays) increases over time. This data, together with the 
rapid and repeatable phage extinction after day 9 in our experiment, indirectly 
supports the idea that S. thermophilus hosts receive a synergistic benefit from 
population-level CRISPR diversity in the context of phage infection. Host diversity is 
a key determinant of pathogen spread [reviewed in Keesing et al. (2010); Chabas et 
al. (2016)], and previous work on P. aeruginosa PA14 and S. thermophilus  has 
shown that population-level CRISPR spacer diversity can limit phage persistence 
(van Houte et al., 2016b). An understanding that population diversity may provide 
such a benefit clarifies other results from our data. Although phage infectivity was 
still possible even with a partial match to the host’s CRISPR array, in the context of a 
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mixed, polyclonal host population, such reduced infectivity may limit phage 
reproduction and transmission, sufficient to cause the rapid extinctions we observed. 
 
In at least some natural environments, bacteria that evolve CRISPR resistance and 
the phage they target can coexist (Andersson & Banfield, 2008). This may be due to 
CRISPR-phage coevolution, as recently observed for a fish pathogen and its phage 
(Laanto et al., 2017), but long-term coexistence may also be explained by various 
other ecological and evolutionary factors that are absent from our simple laboratory 
environments (van Houte et al., 2016a). For example, previous experiments suggest 
that longer periods of bacteria-phage coexistence are reached when experimental 
treatments contained multiple different phages (Paez-Espino et al., 2013; Paez-
Espino et al., 2015). Further, phage under these conditions were found to escape not 
only by mutation, but also by recombination (Paez-Espino et al., 2015). This is 
consistent with observations from other natural environments where phage 
recombinants were correlated with CRISPR activity (Andersson & Banfield, 2008). 
These examples highlight how biotic and abiotic complexities may be key in shaping 
the ecological and evolutionary dynamics of host-pathogen interactions, which we 
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“Diversity is one of our greatest strengths” – Bernie Sanders 
 
In this thesis, I have sought to examine the role of diversity in bacteria-phage 
ecology and evolution. Broadly, I have presented novel insights into why host 
diversity can limit pathogen spread, the synergy between the processes involved, 
and some of the coevolutionary consequences. First, the density of susceptible hosts 
is a key determinant of pathogen success. Second, the close relationship between 
the density of susceptible hosts and population diversity influences if and how 
coevolution can maintain host-pathogen coexistence. Finally, I consider the 
coevolutionary dynamics that can emerge in the context of a diversity-generating 
mechanism. 
 
Generation and maintenance of CRISPR diversity  
 
I have shown that greater diversity leads to less phage adaptation to overcome 
immunity, which increases host fitness. However, different CRISPR-Cas immune 
systems generate different levels of spacer diversity. For example, while the 
CRISPR-Cas immune system of P. aeruginosa PA14 evolves high diversity in 
response to DMS3vir, leading to rapid phage extinction, I found that S. thermophilus 
coevolves with 2972 because of low initial CRIPSR diversity. Why not evolve higher 
levels of diversity? 
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One of the key features of CRISPR-Cas immunity is that different spacers do not 
differ in their host fitness effects (Childs et al., 2014), and so diversity is unlikely to 
be generated by trade-offs among different immune alleles. CRISPR diversity in 
simulated and natural settings instead seems to be characterized by multiple 
dominant CRISPR strains that periodically sweep to fixation and create diversified 
bacteria-phage communities (Childs et al., 2012; Iranzo et al., 2013). Evidently then, 
different degrees of competition among CRISPR strains are unlikely to explain 
differences in the de novo generation of CRISPR diversity.  
 
An alternative explanation is that differences in phage pressure alter the degree of 
CRISPR diversity. Indeed, parasites are often invoked to explain the maintenance of 
diversity in host resistance alleles (Brockhurst et al., 2014), and “hot spots” of 
parasite pressure can select for sexual reproduction as a diversity-generating 
mechanism (Gomulkiewicz et al., 2000; Thompson, 2005; King et al., 2011). A role 
for phage pressure in the degree of CRISPR diversity seems likely, as higher force 
of infection could result in more sampling of the phage genome via spacer 
acquisition. A caveat here is that, beyond a certain threshold, a host population’s 
CRISPR system is unable to clear phage rapidly enough for coexistence to occur, as 
seen in the 109 phage treatment in Chapter 4. Below this threshold, however, further 
study would be required to compare levels of CRISPR diversity between host 
populations inoculated with different concentrations of phage.  
 
Another possible explanation for differences in CRISPR diversity that CRISPR 
systems may have evolved different spacer acquisition rates as a result of prevailing 
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conditions in their evolutionary history. Recently, several studies have considered 
how factors such as temperature and mutation rates may explain the presence or 
absence of CRISPR systems (Drake, 2009; Weinberger et al., 2012; Weissman et 
al., 2018b). There has been comparatively little research attention given to how biotic 
or abiotic factors might affect key aspects of CRISPR systems, in particular those 
related to diversity, such as the rates of spacer acquisition and loss. For example, 
the different evolutionary histories of P. aeruginosa PA14 and S. thermophilus could 
explain why the CRISPR system of the former generates more diversity than that of 
the latter. Future work should investigate these mechanistic differences among 
CRISPR systems, as this would provide more clarity as to role of diversity in 
CRISPR-phage interactions in terms of coexistence, coevolution, and clinical effects.   
 
Host-pathogen specificity networks 
 
The BIM-phage library is an example of matching-allele network: each host genotype 
can be infected by one pathogen genotype, and vice versa. Previous work has 
examined how different coevolutionary processes can structure the pattern of 
infection networks (Poullain et al., 2008; Beckett & Williams, 2013; Fortuna et al., 
2019). In Chapter 3, I experimentally demonstrate the reverse – how the pattern of 
an infection network influences the coevolutionary process. Given then that CRISPR-
phage systems can be used to test the coevolutionary consequences of infection 
networks, further study could be undertaken to understand how this model system 
might be extended. 
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Diversity in host resistance is captured in several theoretical models by assumptions 
regarding the structure of the host-pathogen infection network (Agrawal & Lively, 
2002). By utilising the molecular basis of CRISPR-phage interactions, assumptions 
regarding the infection network could be replicated in vitro to validate model 
predictions. The effectiveness of validating models with experiments on CRISPR-
phage is in fact demonstrated by Chabas et al. (2018). Another potential use for 
experimental CRISPR-phage infection networks is to replicate those found in nature. 
Many natural host-pathogen systems exhibit specificity networks, for example in 
Daphnia magna (Luijckx et al., 2013), and marine archaea and their phage (Flores et 
al., 2013). Future experimental work could construct networks observed in natural 
host-pathogen systems using a CRISPR-phage library. With this model system, it 
would be possible to how different ecological conditions affect the coevolutionary 
consequences of infection networks, as well as provide insight into the genotypic and 




The instances of phage evolving host shift in the most diverse treatments in Chapter 
3 were possibly related to a small initial escape phage epidemic establishing on 
susceptible hosts, which allowed host shift to occur. Although host shift only led to 
transient phage survival in our experiment, the effect of a susceptible host fraction in 
the context of a diverse, mostly-resistant population may have implications for more 
complex host-pathogen systems. Importantly, the results I have presented in this 
thesis are derived from experiments where bacteria and phage interact in a well-
mixed and relatively homogenous liquid culture. Realistically, the majority of hosts 
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and pathogens are patchily distributed into subpopulations. A question which 
warrants further study therefore is: how does spatial heterogeneity interact with host 
diversity, and what are the coevolutionary consequences?  
 
Metapopulation dynamics in host-pathogen systems have already been shown to 
influence local adaptation (Morgan et al., 2005), coevolutionary rate (Brockhurst et 
al., 2007), host-pathogen coexistence (Schrag & Mittler, 1996), and the evolution of 
alternative immune mechanisms (Chabas et al., 2016). Potentially, host 
subpopulations with intermediate levels of diversity might promote the evolution of 
host shift or host range expansion. These coevolutionary “hot-spots” (Gomulkiewicz 
et al., 2000; Thompson, 2005) could then conceivably act as sources of novel 
pathogen genotypes. Future work should therefore examine how the effects of host 
diversity and metapopulation dynamics interact, for example in terms of how host 
immigration can alter subpopulation diversity and the resulting epidemiology and 
coevolutionary impacts on the host-pathogen metapopulation. 
 
Pathogen diversity also matters 
 
Less well-understood is how pathogen diversity may interact with host diversity. Like 
their hosts, pathogens are often diverse (Haldane, 1949; Hudson et al., 2006; Telfer 
et al., 2010). A small number of studies have investigated how host and pathogen 
diversity might interact and influence epidemiology and host success. Experiments 
with the water flea Daphnia magna and its microsporidium parasite Octosporea 
bayeri found that parasite diversity did not have a notable effect on parasite 
prevalence when interacting with mono- or polyclonal hosts (Altermatt & Ebert, 
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2008). However, a later study in a similar system found that diverse parasites were 
more successful in both mono- and polyclonal hosts (Ganz & Ebert, 2010). In 
bacteria-phage systems, infection with clonal or diverse 2 does not affect the 
likelihood of resistance evolution in P. fluorescens (Gorter et al., 2015). In the 
context of CRISPR-Cas, infection by clonal or diverse phage can alter the 
evolutionary dynamics of bacterial immunity at the population- and individual-levels 
(Broniewski et al., 2020). A recent meta-analysis suggested that there is not a 
significant interaction between host and pathogen diversity (Ekroth et al., 2019), 
however all but one study analysed to derive this result did not make pathogen 
diversity explicit nor included it as a controlled variable. The effect of relative host-
pathogen diversity, if any, on pathogen success is consequently poorly-understood 
and ambiguous.  
 
Two further questions regarding pathogen diversity arise from the work presented in 
this thesis. First, how do relative levels of host and pathogen diversity influence the 
population dynamic and coevolutionary trajectories of host-pathogen systems? One 
hypothesis is that the dilution effect mediated by host diversity still limits a diverse 
pathogen population, as higher pathogen diversity cannot overcome the problem of 
decreased contact rates with susceptible hosts. Alternatively, negative individual-
level effects on the amplification of different phage genotypes may be balanced by 
positive population-level effects on overall phage population growth. This could be 
tested using the matching-allele model of CRISPR-phage specificity presented in 
Chapter 3. Second, how do the impacts – if any - of relative levels of diversity 
depend on the pattern of host-pathogen specificity? Does host diversity beget 
pathogen diversity through increased specialisation, or are pathogens with broad 
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host ranges more likely to emerge when hosts are diverse? Simulations suggest that 
bacteria and phage can coevolve to form highly-diversified communities (Childs et 
al., 2012), and the results I presented in Chapter 4 suggest that the ARD led to 
bacteria and phage diversification. However, other factors such as stochastic 
transmission chains (Antia et al., 2003), or the balance between the availability of 
susceptible hosts and selection pressure from host diversity (Chabas et al., 2018) 
could instead favour host range expansion at an individual-level, as I demonstrated 




This thesis has examined how host diversity can shape bacteria-phage dynamics 
through both ecological and evolutionary effects. However, there is a need for further 
understanding of how the effects of immune diversity affects bacteria-phage 
dynamics in more realistic – and therefore more complex – environments. Life 
history trade-offs, alternative specificity networks, metapopulation dynamics, and 
phage diversity and evolution are just a small number of the possible other factors 
that can alter the tempo, mode, and course of bacteria-phage coevolution. Capturing 
the vast complexity of microbial communities requires a concerted combination of 
theoretical, experimental, and observational studies. Work that approaches such 
complexity is key to tackling the specific challenges posed by bacteria, in particular 
the treatment of bacterial infections. More refined computational, bioinformatic, and 
experimental techniques continually offer new ways to build bridges between the lab 
bench and a patient’s bedside, or the computer screen and the geothermal pool.   
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Bacteria-phage interactions are also an ideal system to test more general ideas 
about host-pathogen dynamics. The work presented in this thesis aids our 
understanding of how host ecology has immediate epidemiological and long term 
evolutionary consequences, and provides evidence for synergy between them. 
Emergent infectious diseases such as SARS-CoV-2 illustrate the urgency of 
fundamental, “blue-skies” work to guide and compliment public health preparations 
and responses.   
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Comparison Hazard Ratio Standard Error z  p  
ΔCRISPR CRISPR     
      
10–2  10–2  0.35  2.31  -1.26 1.00 
10–3  10–3  0.24  2.12  -1.93 0.84 
10–4  10–4  0.19  2.31  -1.98 0.81 
10–5  10–4  1.46  2.03  0.53 1.00 
10–6  10–6  0.10  2.31  -2.80 0.24 
10–7  10–7  1.31  2.03  0.39 1.00 
10–8  10–8  4.36  2.11  1.97 0.82 
10–9  10–9  2.68  2.08  1.34 0.99 
 
Table A2.1 Tukey’s significant difference tests of phage extinction hazard ratios 





 CRISPR Sensitive SM 
Bottleneck Mean 95% CIs  Mean 95% CIs  Mean 95% CIs  
       
10 –2  0.92  0.87–0.96 0.04  0.02–0.08 0.03  0.01–0.07 
10–3  0.88  0.82–0.93 0.03  0.01–0.07 0.08  0.05–0.14 
10–4  0.76  0.69–0.83 0.05  0.02–0.09 0.19  0.13–0.26 
10–5  0.82  0.75–0.88 0.08  0.05–0.14 0.10  0.06–0.15 
10–6  0.38  0.27–0.49 0.61  0.50–0.72 0.01  0.00–0.06 
10–7  0.24  0.17–0.31 0.73  0.65–0.80 0.03  0.01–0.07 
10–8  0.13  0.08–0.19 0.88  0.81–0.92 0.00  0.00–0.00 
10–9  0.13  0.08–0.20 0.87  0.80–0.92 0.00  0.00–0.00 
       
Table A2.2 Mean relative frequency and 95% CIs of CRISPR, sensitive and SM 









 CRISPR Sensitive SM 
Bottleneck Mean 95% CIs  Mean 95% CIs  Mean 95% CIs  
       
10 –2  0.85  0.79–0.91 0.03  0.01–0.07 0.11  0.07–0.17 
10–3  0.81  0.74–0.86 0.05  0.02–0.09 0.15  0.09–0.20 
10–4  0.75  0.68–0.82 0.08  0.04–0.13 0.17  0.12–0.24 
10–5  0.78  0.71–0.84 0.08  0.05–0.14 0.14  0.09–0.20 
10–6  0.74  0.66–0.80 0.13  0.08–0.18 0.13  0.09–0.18 
10–7  0.60  0.52–0.68 0.24  0.18–0.32 0.16  0.11–0.20 
10–8  1.00  1.00–1.00 0.00  0.00–0.00 0.00  0.00–0.00 
10–9  NA  NA  NA  NA  NA  NA  
       
Table A2.3 Mean relative frequency and 95% CIs of CRISPR, sensitive and SM 
immune phenotypes in the bacterial culture at 3 d.p.i. when host was bottlenecked 







 CRISPR Sensitive SM 
Bottleneck  Mean 95% CIs  Mean 95% CIs  Mean 95% CIs  
       
10–4 
bottleneck 0.76  0.69–0.82  0.05  0.00–0.09 0.19  0.13–0.26 
Small 
dilution  0.56  0.44–0.67  0.39  0.28–0.50 0.06  0.02–0.12 
10–6 
bottleneck 0.37  0.27–0.49  0.61  0.49–0.72 0.01  0.00–0.06 
Large 
dilution  0.08  0.01–0.0.32 0.92  0.68–0.99 0.00  0.00–0.00 
       
 
      
Table A2.4 Mean relative frequency and 95% CIs of CRISPR, sensitive and SM 
immune phenotypes in the bacterial culture at 3 d.p.i. when host was either 





Figure A2.1 Host population dynamics when WT P. aeruginosa PA14 host is 
bottlenecked in the absence of phage (phage-negative control). Mean colony-
forming units (c.f.u.) ml–are shown for different bottleneck treatments (ranging from 
10-2-10-9 dilutions at each transfer, as indicated above each panel). The detection 
limit is 200 c.f.u. ml-1. Error bars correspond to 95% confidence intervals (CIs). N = 6 





Figure A1.2 Boxplots of DMS3vir titre (plaque-forming units (pfu) ml-1) after 
overnight incubation in used and new media (N=6). Used media was generated by 
inoculating fresh 6ml of M9 minimal media (supplemented with 0.2% glucose) from 
10-2-10-9 from an overnight culture of WT P. aeruginosa PA14, followed by overnight 
incubation at 37˚ and 180rpm. Cultures were then sampled to measure host density 
(purple points and bars are the median, minimum and maximum colony-forming units 
(cfu) ml-1). To remove bacterial cells and generate preparations of used media, 5ml 
of each culture was then centrifuged at 3500rpm for 25 mins, and filtered through 
0.45µm filters into clean glass vials. 108 pfu ml-1 DMS3vir was then added to each 
preparation, and also to fresh (new) media. To measure phage titre, samples of the  
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(Figure A1.2 caption contd.) 
preparations then underwent a chloroform extraction followed by spot assays on a 
top lawn of P. aeruginosa PA14 csy3::lacZ. The preparations were then incubated 
overnight at 37˚ and 180rpm. The next day, phage titres were again measured using 





Figure A2.3 Mean relative frequencies of bacterial clones with CRISPR immunity, 
surface mutation (SM) resistance, or sensitive phenotypes, at 3 days post-infection. 
A 10-4 or 10-6 bottleneck corresponds to either 0.6µl or 0.006µl culture, respectively, 
in 6ml of fresh media at each transfer. A 10–4 dilution corresponds to 0.6µl culture in 
6 ml of fresh media at each transfer, and a 10-6 dilution corresponds to 0.6µl culture 
in 600ml of fresh media at each transfer (see Materials & Methods). Error bars 




Figure A2.4 Mean relative frequencies of bacterial clones with CRISPR immunity, 
surface mutation (SM) resistance, or sensitive phenotypes, at 3 days post-infection 
in a ∆CRISPR background A) When both host and phage were bottlenecked and B) 
when host was bottlenecked and phage supplemented at each transfer. Error bars 
correspond to 95% confidence intervals (CIs) N=6 for all treatments.  
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Figure A2.5 Phage dynamics when both only the host is bottlenecked in A) CRISPR 
background and B) ∆CRISPR control. Mean plaque-forming units (p.f.u.) ml-1 are 
shown. Values of 100 represent phage titres of zero, rather than one. Error bars 
correspond to 95% confidence intervals (CIs). N=6 for all treatments. 
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Appendix to Chapter 3 - Supplementary Materials & Methods 
 
Library of BIMs and escape phages 
 
11 P. aeruginosa PA14 bacteriophage-insensitive mutants (BIMs) that were known 
to have a single CRISPR2 spacer were selected from the collection of clones used in 
van Houte et al. (2016b). The additional 13 BIMs were generated by evolving P. 
aeruginosa PA14 in the presence of DMS3vir. 6ml of M9 minimal media 
(supplemented with 0.2% glucose; M9m) was inoculated with approximately 106 
colony-forming units (cfu) of WT P. aeruginosa and 104 plaque-forming units (pfu) of 
phage in glass vials. After 24hrs, samples from the infection were plated on LB agar. 
Potential CRISPR clones were identified through phenotypic and PCR analyses as 
described previously (Westra 2015; van Houte 2016). CRISPR amplicon sequencing 
(SourceBioscience, UK) confirmed that each spacer carried by a BIM was unique, so 
that all clones used in downstream experiments carried a different spacer. Spacer 
sequences were mapped against the DMS3vir genome (Genbank accession: 
NC_008717.1) using Geneious v9.1.8 (Kearse et al., 2012) to confirm that spacers 
did not target overlapping regions of the phage genome. See Table S1 in Supporting 
Information for the spacer sequences of each BIM.  
 
To generate 24 phage clones that could infect each BIM (escape phage), 15ml LB 
was inoculated with approximately 106 cfu of a single BIM and approximately 106 pfu 
DMS3vir. We also added approximately 106 of P. aeruginosa PA14 csy3::lacZ to 
provide a pool of sensitive hosts on which phage could replicate and hence supply 
novel escape mutations. These cultures were then incubated overnight at 37˚C and 
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180rpm.  Escape phage from these amplifications were identified by spot assay on a 
top lawn of the BIM with which they were originally mixed, and were then plaque-
purified to ensure a monoclonal phage stock. Each escape phage was challenged 
against the entire BIM library to check for a one-to-one infection match. A successful 
infection was defined if a clear lysis zone was visible in the top lawn of the target 
BIM.  
 
Generating labelled BIMs 
 
The BIMs chosen for transformation were such that a single clone could be 
monitored in each of the 3-clone mixtures (that is, BIMs 1, 4, 7, 10, 13, 16, 19, and 
22; see Table S1), which enabled us to measure relative frequency and fitness of a 
labelled BIM through time by performing a blue:white screen when plating on LB 
agar supplemented with 40µg/ml X-gal. 
 
All cloning reactions to generate the labelled BIMs were carried out according to 
manufacturers’ instructions unless stated otherwise. Restriction enzymes, Antarctic 
phosphatase, and T4 DNA ligase were purchased from NEB; High-Fidelity (HF) 
versions were used if available. Strains, primers, and plasmids used for molecular 
work are outlined in Table S2. We used the synthetic mini-Tn5 transposon vector 
pBAMD1-6 (Martínez-García et al., 2014) to deliver the lacZ gene to target BIMs. 
pBAMD1-6 is a non-replicative vector in P. aeruginosa encoding a Tn5 transposase, 
which allows for insertion of a gentamicin resistance gene (GmR) as well as any 
cargo genes into the bacterial chromosome. To introduce lacZ as a cargo gene, we 
amplified it from PA14 csy3::lacZ using primers lacZ_amp_fw and lacZ_amp_rv 
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(Table S2) using Phusion High-Fidelity Polymerase (ThermoFisher). The PCR 
product was cleaned up (QIAgen PCR cleanup kit) and sub-cloned into pMA-
RQ_Cas (Walker-Sünderhauf, unpublished) using NcoI-HF and KpnI-HF to generate 
a construct in which lacZ gene expression is driven by a constitutive -lactamase 
promoter P3 (Genbank accession: J01749, region 4156..4233). Using standard 
molecular cloning protocols and restriction enzymes HindIII-HF and KpnI-HF, this 
promoter and the downstream lacZ gene was inserted into pBAMD1-6 to generate 
pBAM1(Gm)_lacZ. pBAM1(Gm)_lacZ was transferred into E. coli MFDpir by 
electroporation. 
 
Tn5 insertions of the recipient BIMs were carried out by conjugative 
pBAM1(Gm)_lacZ delivery. E. coli MFDpir + pBAM1(Gm)_lacZ was used as donor 
and grown overnight in 5ml LB + 0.3mM diaminopimelic acid (DAP) + 30 µg/ml 
gentamicin at 37˚C, 180 rpm. Recipient BIMs were grown overnight in 5ml LB at 
37˚C, 180rpm. 10ml of fresh media was inoculated from these overnight cultures, 
and grown at 37˚C and 250rpm until OD600 ~ 0.6, then pelleted and washed twice in 
1x M9 salts, and resuspended in 1ml 1 x M9 salts. 600µl of donors were mixed with 
200µl recipients, pelleted, and resuspended to a volume of 100µl. The entire donor-
recipient mixture was pipetted onto sterile 0.2µm microfiber glass filters (Whatman) 
on LB agar + 0.3mM DAP plates and incubated for 2 days at 37˚C. To recover cells, 
filters were placed into 2.5ml LB and vortexed. 100µl of recovered cells were plated 
onto LB agar + 30 µg/ml gentamicin + 40µg/ml X-gal + 0.1mM IPTG plates and 
incubated at 37˚C for 2 days to select for BIMs with Tn5 insertions in their genome 
(absence of DAP selects against the donor strain). 
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Because Tn5 inserts at random positions in the P. aeruginosa genome, this may 
affect fitness. We therefore sampled three blue colonies of each transformed BIM 
and conducted 24hr competition experiments against their untransformed 
counterpart to verify their fitness was unaffected. The relative fitness of the 
transformed BIM was calculated as described previously (Wn = [(fraction 
transformant at tn) * (1 – (fraction stain transformant at t0)) ] / [(fraction transformant 
at t0) * (1 – (fraction transformant at tn)])(Westra et al., 2015). If Tn5 insertion 
disrupted the CRISPR-Cas system, the transformed BIM would regain susceptibility 
to ancestral DMS3vir. We therefore checked for this by spotting ancestral DMS3vir 
on a top lawn of the transformed BIM. If no clear lysis zone was visible on the top 
lawn, we determined that the CRISPR-Cas system was functional. These checks 
confirmed that transformation with pBAM1(Gm)_lacZ did not affect relative fitness of 





Figure A3.1 Density of surface mutants, all CRISPR clones, and the 
susceptible CRISPR clone 
Population dynamics of the bacterial host population at different levels of CRISPR 
allele diversity in the host population (panels). Lines show the density expressed as 
colony-forming units (cfu) ml-1 in individual replicates at each day post-infection (x-
axis). Line colours indicate host immunity: P. aeruginosa PA14 ∆pilA surface mutant, 
which is completely resistant to phage; all CRISPR clones from the BIM library; and 




Table A3.1 Sequence of spacers in the CRISPR2 locus of each of the 24 
bacteriophage-insensitive mutants (BIMs) used in the co-culture experiment. Clones 
transformed to carry a lacZ reporter gene using pBAM1(Gm)_lacZ are highlighted in 
blue. 























Table A3.1 contd. 






Table A3.2 Plasmids, Primers, and Strains used for molecular cloning work.  
Plasmids 
Plasmid Reference Genbank 
accession 
number 




 100 μg/mL Ampicillin, 50 
μg/mL Gentamicin, 0.3 mM 
diaminopimelic acid. 
Needs a pir strain to 
replicate. 
pBAMD1-6 Martinez-Garcia 
et al. 2014 
KM403115 
pBAM1(Gm)_lacZ This study  
Primers 
Primer Sequence (5’  3’) Usage 
lacZ_amp_fw TTACCATGGATGATTACGGAT 
TCACTGGCCGTCGT 
Amplification of lacZ from 
PA14 csy3:lacZ. Adds 
NcoI and KpnI restriction 




Table A3.2 contd.  
 
Bacterial Strains 




Zegans et al. 2009 Template for lacZ 
amplification. 
E. coli CC18λpir NEB Cloning of promoter + lacZ 
onto pBAM1(Gm) 
E. coli MFDpir Ferrieres et al. 2010 Donor strain for 
pBAM1(Gm)_lacZ delivery 
P. aeruginosa PA14 
BIMs 




Table A3.3 Primers used to amplify and sequence the protospacers of interest of 
phage that were shown to have undergone host shift (lost infectivity to the original 
clone and could only infect a new clone) from the phenotypic assay. The first column 
indicates if the protospacer was the original pre-evolved or the new protospacer, with 
the identity of the BIM the phage could infect shown in brackets. The primer 
sequence and binding direction are shown, and if the primer was used for PCR or 
sequencing reactions. 





GTCGCACGGAATGTTCAGCGAG R Sequencing  
Original (13) 
TCTGGCCAGGCGCTCACAAACAA  F 
PCR  
GAGCGGCTTTGGCACCTGGAAC R 
CCAAGTGTCGCTGCCGATCA R  Sequencing  
New (10) 
AGCTGTCCACTGCGCTGGAC  F 
PCR  
CCGGAACAGATGATCCCGTT R 




AGGTACTGAAGTTTTTGGAGGG  R 
CCGCTGCTATCCAGACGGCC F Sequencing  
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Table A3.4 Protospacer sequences of evolved phage clones which showed host 
shift according to the phenotypic assay from replicate 3 of the 24-clone treatment at 
1 day post-infection (dpi). The CRISPR-targeted protospacer and PAM sequences of 
the ancestral (WT) phage and of the pre-evolved phage are shown. Numbers 1-12 
are independent phage isolates from the treatment, replicate and timepoint of 
interest. The second column indicates if the protospacer was the original pre-evolved 
or the new protospacer, with the identity of the protospacer shown in brackets. 
Protospacer-adjacent motif (PAM) and protospacer sequences are shown 
separately. SNPs and deletions, relative to WT DMS3vir, are highlighted in red. 
 
24-clone, replicate 3, 1 dpi 





protospacer 7  AG CGCTCGCCGTCGAGGACCTGTACTGCGACAAC 
1 GG CGCTCGCCGTCGAGGACCTGTACTGCGACAAA 
2 GG CGCTCGCCGTCGAGGACCTGTACTGCGACAAA 
3 GG CGCTCGCCGTCGAGGACCTGTACTGCGACAAA 
4 GG CGCTCGCCGTCGAGGACCTGTACTGCGACAAA 
5 GG CGCTCGCCGTCGAGGACCTGTACTGCGACAAA 
6 GG CGCTCGCCGTCGAGGACCTGTACTGCGACAAA 
7 GG CGCTCGCCGTCGAGGACCTGTACTGCGACAAA 
8 GG CGCTCGCCGTCGAGGACCTGTACTGCGACAAA 
9 GG CGCTCGCCGTCGAGGACCTGTACTGCGACAAA 
10 GG CGCTCGCCGTCGAGGACCTGTACTGCGACAAA 
11 GG CGCTCGCCGTCGAGGACCTGTACTGCGACAAA 




Table A3.4 contd. 
24-clone, replicate 3, 1 dpi 





protospacer 7 GG TAGCTGCGGCGGGACCCGGCGGACCAGCTCGG 
Pre-evolved 
protospacer 10 GG CAGCTGCGGCGGGACCCGGCGGACCAGCTCGG 
1 GG CAGCTGCGGCGGGACCCGGCGGACCAGCTCGG 
2 GG CAGCTGCGGCGGGACCCGGCGGACCAGCTCGG 
3 GG CAGCTGCGGCGGGACCCGGCGGACCAGCTCGG 
4 GG CAGCTGCGGCGGGACCCGGCGGACCAGCTCGG 
5 GG CAGCTGCGGCGGGACCCGGCGGACCAGCTCGG 
6 GG CAGCTGCGGCGGGACCCGGCGGACCAGCTCGG 
7 GG CAGCTGCGGCGGGACCCGGCGGACCAGCTCGG 
8 GG CAGCTGCGGCGGGACCCGGCGGACCAGCTCGG 
9 GG CAGCTGCGGCGGGACCCGGCGGACCAGCTCGG 
10 GG CAGCTGCGGCGGGACCCGGCGGACCAGCTCGG 
11 GG CAGCTGCGGCGGGACCCGGCGGACCAGCTCGG 




Table A3.5 Protospacer sequences of evolved phage clones which showed host 
shift according to the phenotypic assay from replicate 5 of the 24-clone treatment at 
2 days post-infection (dpi). The CRISPR-targeted protospacer and PAM sequences 
of the ancestral (WT) phage and of the pre-evolved phage are shown. Numbers 1-8 
are independent phage isolates from the treatment, replicate and timepoint of 
interest. The second column indicates if the protospacer was the original pre-evolved 
or the new protospacer, with the identity of the protospacer shown in brackets. 
Protospacer-adjacent motif (PAM) and protospacer sequences are shown 
separately. SNPs and deletions, relative to WT DMS3vir, are highlighted in red. 
24-clone, replicate 5, 2 dpi 
Phage Protospacer 
PAM 





protospacer 13 GA TGGGGACACGGGACGCGGTAGATACGCAAGCC 
1 GG TGGGGACACGGGACGCGGTAGATACGCAAGCC 
2 GG TGGGGACACGGGACGCGGTAGATACGCAAGCC 
3 GG TGGGGACACGGGACGCGGTAGATACGCAAGCC 
4 GG TGGGGACACGGGACGCGGTAGATACGCAAGCC 
5 GG TGGGGACACGGGACGCGGTAGATACGCAAGCC 
6 GG TGGGGACACGGGACNCGGTAGATACGCTAGCC 
7 GG TGGGGACACGGGACGCGGTAGATACGCAAGCN 







Table A3.5 contd. 
24-clone, replicate 5, 2 dpi 





protospacer 13 GG TGCGGCAGGAGCGGCAGCGGGCGGCGGCAGTT 
Pre-evolved 
protospacer 21 GG TGCGGCAG--------------------CGGGCGGNGGCAGTT 
1 GG T--------------------GCGGCAGCGGGCGGCGGCAGTT 
2 GG T--------------------GCGGCAGCGGGCGGCGGCAGTT 
3 GG T--------------------GCGGCAGCGGGCGGCGGCAGTT 
4 GG T--------------------GCGGCAGCGGGCGGCGGCAGTT 
5 GG T--------------------GCGGCAGCGGGCGGCGGCAGTT 
6 GG T--------------------GCGGCAGCGGGCGGCGGCAGTT 
7 GG T--------------------GCGGCAGCGGGCGGCGGCAGTT 
8 GG T--------------------GCGGCAGCGGGCGGCGGCAGTT 
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Figure A4.1 Proportion of hosts resistant to phage that were from the host’s past, 




Figure A4.2 Relative importance of fluctuating selection dynamics (FSD) to arms 
race dynamics (ARD). Under FSD, pathogen genotypes should differ in their 
infectivity to hosts from contemporary and non-contemporary environments. Scores 
represent the ratio of the variance in infectivity due to host environment alone 
explained by variance in infectivity among genotypes, derived from GLMMs with 
environment as a fixed effect and phage genotype as a random effect. Residuals 
were square-root transformed to introduce a normal distribution in line with model 





Figure A4.3 Relationship of host susceptibility to A) the number of spacers acquired 
per clone and B) sequence diversity in terms of the pairwise difference among 
spacer sequences from the phenotypic data. Points show raw data per clone, with 
random noise added to give a better indication of the number of occurrences of a 
given measurement. The dashed line is the smoothed logistic (binomial) regression 





Supplementary Table Captions 
 
Table A4.1 
Infectivity matrices from the phenotypic assay (see Experimental Methods). The 
timepoint from which hosts and phage originated is shown. Each 12x12 block is a 
timeshift challenge within each replicate (1-8). In each block, columns 1-12 are 
individual bacterial clones and rows 1-12 are individual phage isolates. 1=plaque 
visible, measured infective; 0=no plaque visible, measured resistant. Phage clones 
selected for protospacer sequence analysis are indicated by black borders. 
 
Table A4.2 
Unique host CRISPR spacers detected by PCR analysis. Replicate and Timepoint 
(days post-infection) of the clone(s) which had a given spacer are shown. Locus is 
either CRISPR1 (CR1) or CRISPR3 (CR3). Start and End are the locations on the 
phage 2972 genome to which the sequences mapped, given in base pairs. N is the 
number of clones in a replicate X timepoint combination (max. 12) that had the 
spacer. GeneID is the NCBI number of the gene which the spacer mapped against, 
and refer directly to the. Gene description is the function (if known) of the region 
targeted by the spacer. 
 
Table A4.3 
Primer sequences used for protospacer analysis. Annealing position indicates where 





Location(s) of SNP(s) detected by PCR when mapped to the phage 2972 genome. 
Replicate and Timepoint (days post-infection) of the phage isolates are shown. 
Phage ID is the number of the phage isolate (rows 1-12 in the infectivity matrices 
[Table A4.1]). SNP in protospacer indicates if the SNP(s) was in the seed sequence 































Replicate Timepoint Locus Start End Sequence N Gene description GeneID 
2 9 CR1 647 676 ATATCGTCCAGACTATCGCAGAATACTGAT 11 Hypothetical protein 5176920 
3 4 CR1 871 900 GTTTTAAGTGGTATTATTATATTATCGAAG 1 Intergenic region 
 
3 9 CR1 871 900 GTTTTAAGTGGTATTATTATATTATCGAAG 10 Intergenic region 
 
3 4 CR1 1020 1049 CATAGCTTACAATGCGGCTCTTAAAGCTGG 4 Terminase small subunit 5176919 
5 9 CR1 2214 2185 GGTCATCACCATTAACTAATCGAATAAGAT 1 Intergenic region 
 
3 9 CR1 2821 2850 TTTTTCGATGAGATATATCAGTACCGATGG 1 Terminase large subunit 5176917 
6 4 CR1 10717 10746 ACGAAGGCTTGGAAAACATTTGATGGTAAC 12 Tail protein 5176903 
6 9 CR1 10717 10746 ACGAAGGCTTGGAAAACATTTGATGGTAAC 12 Tail protein 5176903 
2 9 CR1 16002 16031 TATGGTGTCGAAACTTTTAAACGTTACAAT 1 Tail protein 5176902 
3 4 CR1 20696 20725 TGGAATAAGGTATCGTGCGTTTTGACAAGC 1 Antireceptor 5176901 
6 9 CR1 22424 22395 CACATGATCTACAACTAGGTCAAGATTGCT 2 Structural protein 5176900 
5 9 CR1 23363 23334 ATAGTTAACGCCTTTACACCGATCGAGGAA 5 Structural protein 5176900 
4 4 CR1 23571 23600 TTGTTAAAAGAAGCACTAGAGGTGATTTAC 12 Hypothetical protein 5176899 
4 9 CR1 23571 23600 TTGTTAAAAGAAGCACTAGAGGTGATTTAC 12 Hypothetical protein 5176899 
6 9 CR1 25561 25531 AAACAAAAAATCTTTGAAGTTTATGACATAC 1 Hypothetical protein 5176893 
5 9 CR1 26669 26639 GCATACCACAGGTATGACCAAAAACAAGAAA 2 Hypothetical protein 5176889 
2 9 CR1 27003 27032 AGATTTATAACATGGAAATTGACGATGAAA 11 Hypothetical protein 5176888 
6 9 CR1 27003 27032 TTTCATCGTCAATTTCCATGTTATAAATCT 2 Hypothetical protein 5176888 
3 9 CR1 27358 27388 AACACTCAAAGAGTTACTTAAATCTGGAAAG 9 Hypothetical protein 5176888 
6 9 CR1 27410 27380 CTGGAAAGCATATTGAGGGAGCTACTCTTG 2 Hypothetical protein 5176888 
3 4 CR1 28744 28773 AGCTATAGTATATACACATAGCGTAGAAGC 3 Helicase 5176886 
6 9 CR1 29124 29095 CAAAATAATTGTGGAAAATCACTGGTAAGT 1 Helicase 5176886 
6 9 CR1 29407 29378 AACAACCATTATTTGGGTTGGCCCGAATAT 1 Helicase 5176886 
3 9 CR1 29618 29647 TTTTCCGTCTTCTTTTTTAGCAAAGATACG 1 Hypothetical protein 5176885 
4 9 CR1 29618 29647 TTTTCCGTCTTCTTTTTTAGCAAAGATACG 11 Hypothetical protein 5176885 
5 9 CR1 29618 29647 TTTTCCGTCTTCTTTTTTAGCAAAGATACG 5 Hypothetical protein 5176885 
 186 
2 1 CR1 29894 29923 TTATGGAGATGGTTGATTACGCAATCAACT 12 Replication protein 5176884 
3 9 CR1 30017 29988 GCGACTGTTTGGTGGTTACTGACTTTTGCT 8 Replication protein 5176884 
1 9 CR1 31582 31611 CTCAGTCGTTACTGGTGAACCAGTTTCAAT 12 Primase 5176883 
3 9 CR1 32557 32584 GTATCAAACCAACGTCCATCAGCCATTC 1 Hypothetical protein 5176882 
7 9 CR3 32554 32584 TCAGAATGGCTGATGGACGTTGGTTTGATAC 11 Hypothetical protein 5176882 
7 4 CR3 32554 32584 TCAGAATGGCTGATGGACGTTGGTTTGATAC 12 Hypothetical protein 5176882 
8 9 CR1 32707 32736 TGAAAAAACGAGGAGCACTCGTAGGAGTGG 12 Hypothetical protein 5176882 
4 9 CR1 33769 33799 CTGCGTGGAACTGTCAGAACATAGTAGACTG 1 Hypothetical protein 5176878 
6 9 CR1 33877 33848 TGGTAACTGAAAGGTCAGTGGAACGGCACG 1 Hypothetical protein 5176878 
6 9 CR1 33998 33968 GTACAGAATTATTGAGGAGTTTATTGAACCT 5 Hypothetical protein 5176878 




   
 





name Primer sequence 
Annealing 
position  
1F ACCAGTTGGAAGGAAAAGCTCT 29733 
2F AGACGGCTCATTTGTGGGTT 911 
3F CAACAGCAGCAAACACTGGG 20496 
4F GACAACGGAAACATCGCACC 28574 
5F GCACACCCTAACTGCGTCAT 34377 
6F TGGACCCCTAGCGGAAGTTA 23291 
7F ATGGCATGTCTAGCGCTCTC 10532 
8F GTGGGCACTGCTAAGAGTGT 32412 
9F TCAATCGGCTTTGAACGCAC 726 
10F CTGAACGTTTCGGTCTTGCC 31485 
11F GAATATCCACGCTGGCGAGA 474 
12F TTGGGGTCGTCCTCACATTG 15809 
13F AATTGAAGCACATCGGGGGA 26835 
14F AGCAAGGAAACTGACTGGCA 2625 
15F GCAGCGCTTGCGATTAGTAT 27206 
16F GTCCGATGTGTGGTCACGAA 29208 
17F TCAACCATTGGGCAGACGAA 33405 



















1 2 5 1 29896     
1 2 6 1 29899     
4 2 1 1 29899     
4 2 2 0       
4 2 3 0       
4 2 4 0       
4 2 5 0       
4 3 1 0       
4 3 2 1 1039     
4 3 3 0       
4 3 4 1 1039     
4 3 10 1 1027     
4 3 11 0       
4 6 3 1 10724     
4 6 4 1 10724     
4 6 5 1 10724     
4 6 6 1 10724     
4 6 9 1 10724     
4 7 1 1 32580     
4 7 2 1 32583     
4 7 12 1 32580     
4 8 1 0       
4 8 6 0       
4 8 8 0       
9 1 7 1 31615     
9 1 8 1 31615     
9 2 1 1 682     
9 2 5 1 682     
9 3 2 1 893 1014   
9 3 3 0       
9 3 9 1 893 1023 29983 
9 3 10 0       
9 3 11 1 893 1024 1027 
9 3 12 1 893 1023   
9 4 2 0       
9 4 3 1 29614 29626   
9 4 4 1 29614     




9 4 8 1 29614 29623   
9 6 1 1 10724     
9 6 8 1 10724     
9 6 9 1 10724     
9 7 1 1 32587     
9 7 2 1 32587     
9 7 5 1 32587     
9 7 6 1 32583     
9 7 9 1 32587     
9 7 10 0       
9 8 1 1 32747     
9 8 2 1 32747     
Ancestral NA 1 0       
Ancestral NA 2 0       
Ancestral NA 3 0       
Ancestral NA 4 0       
Ancestral NA 5 0       
Ancestral NA 6 0       
Ancestral NA 7 0       
Ancestral NA 8 0       
Ancestral NA 9 0       
Ancestral NA 10 0       
Ancestral NA 11 0       
Ancestral NA 12 0       
Ancestral NA 13 0       
Ancestral NA 14 0       
Ancestral NA 15 0       
Ancestral NA 16 0       
Ancestral NA 17 0       
Ancestral NA 18 0       
 
 
 
 
 
 
 
 
 
 
